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Abstract
Factors Associated With Household Contacts’ Tuberculosis Testing And Evaluation
by
Elvy Barroso
Advisor: Elizabeth Capezuti

Contact investigation (CI) is one of the core elements of tuberculosis (TB)
control. It is intended to achieve early identification of contacts who may have been
exposed to a patient with infectious active TB and contacts who may benefit from
treatment for latent tuberculosis infection (LTBI). LTBI is an infection in which the
Mycobacterium tuberculosis organisms cause no signs and symptoms but the infection
can be reactivated and develop into full-blown active TB disease. Failure to be identified
as a contact is the primary reason for disease development in more than half of TB
patients, thus a complete and timely CI is crucial for decreasing the transmission and
incidence of TB. However, ensuring that contacts get tested and evaluated is challenging.
A retrospective study of deidentified data extracted from the NYC TB registry was
conducted to assess the demographic characteristics associated with 3008 household
contacts’ decision to undergo TB testing (n=2850), evaluation (n=1037), and treatment
for LTBI (n=863) from 2010 to 2014. A secondary aim was to examine if there are
differences in proportion of contacts tested and evaluated based on type of provider
(nurse versus and public health advisors). Multiple logistic regression analysis identified
significant household contact characteristics associated with each decision point. The age
of the household contacts was associated with acceptance of TB testing, such that the
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older the person, the less likely they were to be tested. Household contacts who are
older, non-US born, and reside in Brooklyn, Queens, and Staten Island were more likely
to have a TB test positive. Among household contacts with a positive TB test, Asians
were more likely to undergo full evaluation while older age, males, and non-US born
were less likely to be fully evaluated. Household contacts who are older, non-US born,
and residing in Brooklyn, Queens, and Staten Island were less likely to accept LTBI
treatment, while Asians and Hispanics were more likely to accept LTBI treatment. In
terms of provider type, proportion of household contacts tested and evaluated did not
differ between nurses and public health advisors.
These study findings identify factors associated with TB testing and evaluation,
and LTBI treatment, which will enable public health agencies to streamline the process of
contact investigation and plan for effective strategies that will increase the number of
household contacts accepting TB testing and evaluation, as well as accepting and
completing LTBI treatment.
Keywords: active tuberculosis, contact investigation, contacts of TB case, case
management, testing, evaluation, barriers
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Chapter 1: Background and Study Purpose
Background
Tuberculosis (TB) is a bacterial disease primarily affecting the lung that remains a
global health problem. The incidence of TB is approximately 9.0 million new cases
globally each year, and approximately 3.3 million cases are missed by health systems as
either undiagnosed or not reported (World Health Organization [WHO], 2014). Of the
new cases, an estimated 1.1 million cases occurred among people living with human
immunodeficiency virus (HIV) and an estimated 480,000 new cases represented multidrug-resistant TB (MDR-TB) (WHO, 2014).
Tuberculosis begins when a person is exposed to someone with active pulmonary
or laryngeal TB disease and develops latent TB infection (LTBI) or secondary TB (new
case of TB) (American Thoracic Society & Centers for Disease Control and Prevention
[CDC], 2000; CDC, 2005; CDC, 2011; WHO, 2006). LTBI is an infection in which the
Mycobacterium tuberculosis (M. tb) organisms cause no signs and symptoms or
radiographic evidence of TB disease; however, when the immune system breaks down,
the infection can be reactivated and develop into full-blown active TB disease (index
case) (CDC, 2011). A single infectious index case (infectious active TB disease) can
infect up to 10 to 15 individuals, known as contacts, over the course of a year (WHO,
2015). Failure to be identified as a contact is the primary reason for disease development
in 54% of TB patients (Chin et al., 2000). For this reason, the Centers for Disease
Control and Prevention (CDC) have identified contact investigation (CI) as a
fundamental strategy for the prevention and control of TB (CDC, 2005). Prompt
identification, testing, and evaluation of contacts through CI is one of the recommended
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strategies for achieving the goal of reducing TB disease and related deaths (CDC, 2005;
WHO, 2014).
CI is the process of identifying, testing, evaluating, and treating all persons who
are at risk for infection with M. tb due to recent exposure to an index case (CDC, 2005;
CDC, 2011). The primary goals of CI are identification of household and non-household
contacts exposed to an index case, prompt testing and evaluation of contacts, and
initiation of treatment of eligible contacts with LTBI and secondary TB (Bureau of TB
Control [BTBC], 2008; CDC, 2005; CDC, 2011; WHO 2012).
Previous studies have demonstrated that CI is an effective tool to achieve early
identification of infectious (active) TB cases, prevent future cases by treatment of
contacts, and break the chain of transmission (Anger et al., 2012; Bayona et al., 2003;
Becerra et al., 2005; Bur et al., 2003; Cates et al., 2015; Davidow et al., 2003; Driver et
al., 2003; Fox et al., 2012; Greenway, et al., 2003; Jereb et al., 2003; Marks et al., 2000;
Mohle-Boetani & Flood, 2002; Reichler et al., 2002; Sia et al., 2010; Verver et al., 2004).
As such, CI plays an integral role toward TB elimination (Anger et al., 2012; Bur et al.,
2003; CDC, 2005).
In New York City (NYC), the TB case manager has an important role in assessing
individuals for TB testing and evaluation during CI. According to state and local
standards, the TB case manager, either a nurse or non-nurse, uses science-based
knowledge to conduct the initial TB interview of the index case. The nurse TB case
manager uses nursing processes to determine the history of TB exposure, signs and
symptoms, coexisting medical conditions, and risk factors; and to collect information
about the patient’s contacts in the household and non-household settings. Nurses also

3
provide education to contacts and facilitate testing and evaluation of all contacts. Their
roles as case manager also involve other public health activities to prevent and control the
spread of TB disease in the community (Campbell, Galanowsky, & Pirog, 2001).
History of TB Control in New York City
As early as the 1920s, the CDC had begun to use TB skin testing to detect
asymptomatic individuals (contacts) exposed to TB disease. The use of chest x-ray
(CXR) supplemented the testing in the 1930s. By the mid-1950s, the health department
(HD) in NYC was taking more than 500,000 CXRs annually. As more patients received
anti-TB medications, the number of sanatoria decreased. A sanatorium is a facility for
long-tern illness associated with TB. From 20 sanatoria operating in the US, only 17
remained in operation. Although patients formerly required years of hospitalization,
average stays in the 1950s dropped to less than 6 months. Despite these developments,
there were still significant problems in TB control. The disease continued to affect
minority groups, whose death rates averaged three to five times those of whites.
Furthermore, the availability of new drugs did not ensure adherence and completion of
treatment. Therefore, the declining rate of TB was deceiving (BTBC, 1999).
By 1960, TB was no longer among the top 10 causes of death in NYC. As a
result, health officials grew more interested in preventing other diseases such as heart
diseases, cancers, and other lung diseases caused by smoking and pollution. The decline
in TB cases led to a decrease in funding for TB control and infrastructure. In 1976, all
sanatoria closed, and TB clinic numbers fell from 20 to nine. Some programs run by the
HD, such as nurse home visits to follow-up on patients’ adherence to treatment (known
as medical management), were de-emphasized. This complacency gave rise to the
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resurgence of TB. Other factors that contributed to the resurgence were worsening
poverty, homelessness, and the influx of immigrants from countries with high prevalence
of TB. However, the major factor in the resurgence of TB was the rise of HIV-related
disease (BTBC, 1990).
In 1990, there were 3,520 cases (49.8 per 100,000 population) of TB in NYC,
which represented a 38% increase (975 cases) since 1989, the highest incidence of TB in
20 years. All cases of TB were assigned to healthcare workers called Public Health
Advisors (PHAs) for case management (BTBC, 1990). The NYC HD chest clinics
started to carry out a program of HIV counseling and TB testing for all persons who had
been exposed to TB disease. The PHAs started home visits to supervise patients on TB
treatment in what was called the supervised therapy program (STP). Each PHA had
about 10 to 12 patients on STP. The focus had shifted to individuals infected with HIV
who were exposed to cases of TB. The PHAs faced tremendous challenges in convincing
contacts to undergo TB testing because of the use of needles to test for TB infection and
the fear of contracting HIV (BTBC, 1991).
In 1992, once again, hospitals and emergency departments were filled with
individuals who were acutely ill with TB. At the peak of this epidemic, there were 3,811
cases (52 per 100,000 population) reported to the HD (BTBC, 1992). NYC accounted for
nearly one out of six patients with active TB in the US. The HD budget for TB control
was nearly tripled from $4M (1986) to $7M (1991) to $11.2M (1992) (BTBC, 1992).
The HD began to rebuild infrastructure to fight TB, such as upgrading laboratory
facilities to examine sputum samples of symptomatic patients; funding the provision of
directly observed therapy (DOT), formerly known as STP; and educating the public about
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the infectious nature of TB (BTBC, 1999). Strict compliance with mandatory reporting
of all cases of TB to the HD was enforced. In addition to the municipal funds, the federal
government, in the form of CDC cooperative agreement funds, doubled the budget (from
$1.2M to $3.7M) to support surveillance activities for MDR-TB (BTBC, 1992).
Since 1993, the TB case rate in NYC has consistently decreased every year
because of interventions by the HD (BTBC, 2008; CDC, 2005; Dye et al., 2013; Fox et
al., 2012; Koh, 2013; Taylor, Nolan, & Blumberg, 2005; Verdier et al., 2011). The CDC
estimates that if previous trends had continued, there would have been nearly 52,000
more cases of TB in the US from 1985 to 1992 (BTBC, 1993).
Problem Statement
Testing of contacts of an index case is one of the most productive methods of
identifying adults and children with TB; however, convincing asymptomatic contacts to
accept TB testing and evaluation is difficult. The national objectives established by the
CDC include that contacts should be identified in 100% of infectious TB cases and to
increase the proportion of contacts tested and evaluated to 93% by 2020 (CDC, 2015). In
2015, of the 577 index cases reported in NYC, the total number of contacts (household
and non-household) identified was 3,920, of which 3,162 (81%) were tested and
evaluated. These 3,920 contacts include 1,149 household contacts, and of these only 83
(7%) were tested (Chorba, 2015). In order to improve this rate in NYC and potentially
nationally, the primary purpose of this study was to identify factors associated with
household contacts’ accepting testing and evaluation between 2010 and 2014.
In 2012, a major change in the case management of TB cases was implemented
by the NYC Bureau of Tuberculosis Control (BTBC) (Appendix Figure A1). Because of
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shortage of TB nurses, the management of TB cases in the DOHMH Chest Clinic was
transferred from TB nurse managers to Public Health Advisors (PHAs), which are nonTB nurse managers. A PHA is a public health worker who assists with implementation
of the activities of the BTBC. The impact of this personnel change on TB testing has not
been evaluated. Thus, as a secondary objective, this dissertation also evaluated the
proportion of contacts tested and evaluated by nurse managers versus PHAs by
comparing cases prior to (January 2010-June 2012) and following (July 2012-December
2014) this change in BTBC protocol for case management.
Theoretical Framework
Getting household contacts to accept testing and evaluation is challenging in part
because household contacts do not manifest symptoms of active TB. They do not feel
sick and thus do not see the importance of TB testing and evaluation. In addition, most
patients have other confounding issues such as HIV, homelessness, and drug addiction,
so that getting tested may not be their priority. Moreover, since educating contacts has
not been found effective (Hirsch-Moverman et al., 2010), this study used Pender’s (2011)
Health Promotion Model (HPM) to guide the examination of factors that influence or
prevent contacts from accepting testing and evaluation for TB (Appendix Figure A2).
Acceptance of TB testing requires a behavior based on deliberate action. The
HPM implies that an understanding of the major determinants of health behavior informs
the counseling of healthy behavior. The philosophical underpinning of HPM is that an
individual is partially shaped by the environment. The environment includes the social,
cultural, and physical factors that influence behavior. An individual’s characteristics that
include the prior related behavior and personal factors such as biological, psychological,
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socio-cultural as well as life experiences shape his or her behavior. The theoretical roots
of HPM derive from social cognitive theory, which stresses the interaction among
behaviors, environment, and community. Families, peers, and health care professionals
influence participation in health-promoting behaviors. The HPM is based on the
following assumptions, which reflect both nursing and behavioral science perspectives
(Pender, 2011): (1) individuals seek to actively regulate their own behavior based on their
interaction with the environment; and (2) health professionals constitute a part of the
interpersonal environment, which exerts influence on a person’s behavior. Therefore, the
person-environment interaction is essential to behavior change, which in this case is
acceptance of TB testing and evaluation. It is expected that uncovering the factors that
determine a contact’s environment will likely lead to more effective counseling of
contacts and healthier behavioral choices for those potentially exposed to TB.
Study Purpose and Research Questions
The primary purpose of this secondary analysis of data extracted from the NYCTB registry was to identify factors associated with household contacts’ testing and
evaluation for TB. The secondary purpose was to compare the proportion of household
contacts tested and evaluated by a nurse case manager versus a PHA.
This secondary analysis addressed two research questions:
1. What are the household contacts’ characteristics associated with TB testing
and evaluation?
2. Are there differences in the proportion of household contacts tested and
evaluated between index cases with a nurse case manager versus index cases
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with a non-nurse case manager, after controlling for potentially confounding
factors?
Significance of the Study
A complete and timely CI is crucial for decreasing the transmission and incidence
of TB. Therefore, testing and evaluation of household contacts exposed to a patient with
active TB disease is of utmost importance (Ailinger and Dear, 1998). The average cost
of hospitalization for TB is $20,100 per case (Holmquist, Russo, & Elixhauser, 2008),
and the productivity loss faced by patients undergoing treatment can cost an average of
$260,000 per case (CDC, 2014).
Understanding the factors that influence household contacts’ decisions will
facilitate development of appropriate strategies that will improve acceptance of TB
testing and evaluation among household contacts. Effective CI interventions can also
increase initiation of LTBI treatment to prevent the development of active TB disease,
reduce the cost of hospitalization due to TB, reduce contacts' productivity loss while
undergoing treatment, improve TB care (Fox et al., 2015; Nyirenda et al., 2006;
Rutherford et al., 2013; Tornee et al., 2005), and accomplish the national CDC objectives
for CI testing and evaluation (CDC, 2015). The long-term goal of this line of research is
to improve the timely treatment of LTBI.
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Chapter 2: Literature Review
Major challenges to the successful control of TB include timely diagnosis and
adequate treatment of infectious active TB (the index case), CI or screening of persons in
close contact with the index case, and treatment of LTBI to prevent its progression to
active TB disease (BTBC, 2008; CDC, 2011; Faccini et al., 2015; Fox et al., 2015; Kwon
et al., 2014). These three core elements are the basis of TB control (BTBC, 2008; CDC,
2005; CDC, 2011). CI, as one of the core elements, is an important policy in TB control
(BTBC, 2008; CDC, 2005; CDC, 2011; Fox, Dobler, & Marks, 2011) and plays an
important role in decreasing the incidence of TB in the US (Taylor, Nolan, & Blumberg,
2005).
The guidelines on CI were first formulated by the American Thoracic Society in
1976. It stated that as soon as an active TB case is diagnosed based on laboratory and/or
clinical findings, investigation of contacts should begin without waiting for positive
cultures if history, sputum smears, and CXR are suggestive of TB (ATS, 1976). CI is the
recommended screening for high-risk groups such as close contacts of a smear-positive
index case, including child contacts younger than 5 years old and contacts who are HIV
infected (Atif et al., 2012; Australasian Society for HIV Medicine, 2010; Fair et al. 2015;
CDC, 2005; CDC, 2011; Hopewell, 2014; Morano-Mendoza, 2010; WHO, 2008; WHO,
2012). The CDC recommends screening of persons who have been in contact with the
index case from 3 months prior to the onset of symptoms in the index case (BTBC, 2008;
CDC, 2011; Davidow et al., 2009; Fenton & Castro, 2005). Current WHO
recommendations suggest that all close contacts of pulmonary TB cases should be
investigated without consideration of age (WHO, 2015).
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In NYC, TB screening includes the use of Tuberculin Skin Test or the bloodbased QuantiFERON test (QFT). The BTBC aims to evaluate at least five contacts per
active TB case. TB testing is initially done before 8 weeks and a repeat testing is done at
8 weeks after exposure to a case of TB. Evaluations of contacts with positive TB test
results include chest-x-ray and medical evaluation made by a health care provider for
possible treatment of LTBI (BTBC, 2008). Besides ensuring that pulmonary smear
positive contacts are routinely evaluated, the BTBC expanded its efforts to evaluate all
contacts to patients aged 15 years and older with culture-confirmed pulmonary or
laryngeal disease. In 1995, an Expanded Contact Investigation Unit was created in the
BTBC to allow rapid evaluation of possible transmission of TB in congregate settings
(e.g., schools, work sites, or other institutions). When indicated, mass tuberculin skin
testing (TST) and education about TB were provided (BTBC, 1995).
Literature Search Method
A literature review was performed to identify trends and barriers to CI worldwide
to inform the retrospective study. This integrative review followed the methods
described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement guidelines (Moher et al., 2009). Initially, a scoping review was
conducted of literature addressing barriers to TB testing and evaluation. Then a search
was conducted of peer-reviewed journals published from 2000 to 2016 using CINAHL,
MEDLINE, PubMed, PLOS ONE, and ProQuest nursing databases. Studies relevant to
the review that were more than 10 years old were also considered. CINAHL and
MEDLINE were searched with the Boolean operators ‘AND’ and ‘OR’ applied to search
for keywords. The search term started with the main keywords “active tuberculosis” and

11
the yield was more than 5,000 articles. Six other keywords were added in all applicable
combinations: “contact investigation,” “contacts of TB case,” “case management,” “TB
testing,” “TB evaluation,” and “barriers to TB testing and evaluation.” More specific
search terms were also applied, as listed in Appendix Table A1a.
In addition to the database search, a hand search was performed of relevant
articles from the reference lists of selected citations, including policies and protocols
concerning CI. Moreover, a search for grey literature was performed on Google Scholar
using the seven keywords.
All titles and abstracts were initially assessed. Full-text articles relevant to the
topic were then further assessed. Only full-text articles with complete data on at least one
of the seven keywords were reviewed. Inclusion criteria were the following: English
language; study design including prospective, case-control, cross-sectional, and case
report; data provided on CI of human subjects with active TB or LTBI; testing of
household contacts and non-household contacts including congregate settings; and
outcomes with the number of contacts tested, number of index cases identified before
testing of contacts, number of contacts positive on the skin test, the TST or the blood-test,
the interferon-gamma release assay (IGRA) test during screening (or other diagnostic
tests), and the number of contacts identified with LTBI and secondary active TB.
Evidence from systematic reviews and meta-analyses was included to gain further
understanding of the topic.
Exclusion criteria included studies in which CI was based on theoretical models
or diagnosis of TB was not made according to clinical, radiologic, or microbiologic
criteria. Editorials and conference abstracts were also excluded from the search.
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Search Outcome
Appendix Figure A3 diagrams the search results using the PRISMA guidelines,
and Appendix Table A1b summarizes the included and excluded studies by database. A
total of 91 articles were identified through the CINAHL, MEDLINE, PubMed, PLOS
One, and ProQuest nursing databases. Twenty additional articles relevant to the topic
were identified through the hand search; these 20 articles were not included in the
quantitative analysis. All 91 abstracts were screened and 15 duplicate articles were
removed; only 76 relevant articles meeting the inclusion criteria were assessed for
eligibility. Thirty-six articles not relevant to the topic were eliminated based on the
exclusion criteria. A total of 40 articles were included in the synthesis: five qualitative
and 35 quantitative studies (including one dissertation).
Critical Appraisal
Critical appraisal checklists were applied using Pearson’s (2004)
recommendations for the five qualitative studies (Appendix Table A2a) and Bowling’s
(2009) recommendations for the 35 quantitative studies (Appendix Table A2b).
Data Extraction
Studies with the most complete data were included. Data extracted from the
studies included the following criteria: study design, sample size, state or country,
location of exposure, selection criteria for index case, selection criteria for contacts, and
screening method employed (Appendix Table A3a); number of index cases, number of
contacts tested or screened, number of contacts not tested or screened, number of contacts
with LTBI, number of contacts with active TB (secondary case), number of contacts

13
placed on LTBI treatment, barriers to testing or screening, and key findings (Appendix
Table A3b).
Definitions Used
Definitions used in this integrative review to describe contacts, CI processes, and
aspects of TB are explained in Appendix Table A4.
Data Abstraction and Synthesis
The guidelines for conducting CI differ worldwide. Some countries have
developed their own guidelines for conducting CI. Most have followed the WHO
recommendation for testing children younger than 5 years of age and persons with HIV
exposed to an index case (WHO, 2008; WHO, 2012). Guidelines should be standardized
with regard to definition of contacts, inclusion and exclusion criteria, time of testing,
method of recruiting, diagnostic tests used, and the data-collection process for monitoring
and evaluation (Fair et al., 2015; WHO 2013). Lack of standardization limits the ability
to analyze data on CI and to generalize the results.
Inconsistencies exist in the literature regarding the use of terminology and
methodology in CI. The majority of studies did not have standard definitions for
contacts, types of contacts identified, or indicators used in CI. Some studies defined a
household contact based on location; that is, a person who lived in the same household as
the index case (Kwon et al., 2014), while other studies defined contacts (non-household)
based on temporal exposure or degree of proximity (Bayona et al., 2003, Marienau et al.,
2010). For example, airline passengers seated for greater than 8 hours within two rows of
an index case are considered close contacts because they are in close proximity and more
likely to be exposed than other passengers (Marienau et al., 2010).
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The process and methods used for CI differ based on epidemiologic
circumstances and availability of resources (WHO, 2012). However, lack of guidance in
methodology can lead to inconsistencies in CI, and this can affect the process of
conducting CI in terms of identifying and prioritizing contacts, as revealed in most
studies in this review. Studies in this synthesis used the standard clinical, radiologic, and
bacteriologic criteria for the diagnosis of active TB disease; however, many showed no
standard method for testing contacts. Globally, the TST and CXR are the most
commonly used tests (Australasian Society for HIV Medicine 2010; CDC, 2011; Joint
Tuberculosis Committee of the British Thoracic Society, 2000; National Institute of
Health and Clinical Excellence, 2006; Richard & Kerri, 2010; WHO, 2012). In the US,
the standard test is the TST (CDC, 2011, Menzies, 2000). Since most candidates for TB
testing are born outside the US, with a history of Bacille Calmette-Guerin (BCG)
vaccination, the US has adopted the use of IGRA for testing contacts (BTBC, 2008;
CDC, 2011, Mazurek et al., 2005). IGRA eliminates the boosting effect and the falsepositive results caused by BCG vaccine and non-tuberculosis mycobacteria (NTM). CI
performed in developing countries with high coverage of BCG vaccination, as shown by
studies in this review, has used only the sputum smear in finding contacts. Furthermore,
some countries have used sputum smear when TST for testing contacts and sputum
culture as part of the bacteriologic criteria were not available (Bayona et al., 2003; Fox et
al., 2015; Ratovoson et al., 2014; Singh et al., 2005). Other countries have used more
sophisticated tests for the diagnosis of TB, especially in the case of an outbreak.
Examples are the use of DNA fingerprinting, polymerase chain reaction (PCR), and
genotyping analysis such as the mycobacterial interspersed repetitive unit-variable
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number tandem repeat (MIRU-VNTR) assay (Anderson et al., 2014; Bur et al., 2003;
Faccini et al., 2015; Fox et al., 2015; Gounder et al., 2014; Ruddy et al., 2004;
Yoshiyama et al., 2010). However, the costs of these tests have hindered their use by TB
programs that have inadequate funding.
The international, national, and local guidelines in the selection criteria for
conducting CI recommend the concentric-circle approach for identifying contacts of an
index case (BTBC, 2008; CDC, 2005; CDC, 2011; Erkens et al., 2010; European CDC,
2013). A concentric-circle approach is a method of testing contacts in order of their
intensity and time of exposure and risk of being infected (BTBC, 2008; CDC, 2005).
Some studies have followed the concentric-circle approach (Bur et al., 2003;
Collins et al., 2003; Faccini et al., 2015; Kettunen et al., 2007; Yun et al., 2003);
however, this review found various other methods as well (Appendix Table A3a). Most
contacts were identified by the index case (Chee et al., 2005; Davidow et al., 2003;
Driver et al., 2003; Fox et al., 2012; Singh et al., 2005; Suggaravetsiri et al., 2003; Wares
et al., 2000), and investigators in retrospective studies used the TB registry for finding
contacts. One study used the “invitation model” as an effective method of identifying
contacts. This is a method in which an index case is asked to invite his or her contacts to
be examined at a health care facility (Chakhaia et al., 2014).
CI is crucial in preventing the development of active TB disease; however, CI is
not considered successful without treatment of LTBI (BTBC, 2008; Bur et al., 2003;
CDC, 2005; CDC, 2011; Chakhaia et al., 2014; Fair et al., 2015). In the US,
approximately 20% to 30% of all contacts have LTBI (CDC, 2005). In NYC in 2015,
267 contacts were eligible for LTBI treatment and 217 (81%) initiated treatment (Chorda,
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2014). The results of studies included in this review showed that the percentage of
contacts not tested ranged from about 0% to 52%, and the percentage of contacts who
initiated LTBI treatment ranged from 7% to 100% (Appendix Table A5). Some studies
did not include any data on the number of contacts who were not tested or the number
who initiated LTBI treatment. The wide range in the percentage of contacts not tested
can be due to the lack of standard criteria for expanding investigations to include those
with less frequent exposure, and the lack of standard procedures for identifying,
screening, and tracking of contacts (Atif et al., 2012; Bur et al., 2003; Chakhaia et al.,
2014; Marienau et al., 2010; Seddon et al., 2013; Shapiro, 2013; Wares et al., 2000;
Yoshiyama et al., 2010; Zellweger et al., 2015). Furthermore, the wide range can be due
to barriers that prevent contacts from adhering to TB testing (Fox et al., 2015). The wide
range in the percentage of contacts who initiated LTBI treatment can be due to the
provider’s lack of knowledge about LTBI treatment or lack of sufficient funding for
treatment (Atif et al., 2007; Chakhaia et al., 2014; Kettunen et al., 2007). It is crucial that
health care providers are educated not only about the disease process but also about the
necessity for LTBI treatment to prevent the development of active TB disease.
This review revealed that the majority of studies conducted on CI were
quantitative with an observational and retrospective design. Biases were reported in
outcomes, owing to the retrospective design of most studies and the lack of suitable
matched controls (Fox et al., 2013). Of the 35 quantitative articles in this review, only
two studies had a design with a matched control group. Only one study was a
randomized controlled trial (RCT) (Fox et al., 2015). The impact of TB testing on
transmission can be established through an RCT, and it is only through an RCT that

17
findings can be generalized. In the absence of an RCT, it is not possible to make strong
recommendations for the implementation of specific interventions in CI (Fox et al.,
2013).
Perceived Barriers in Testing of Contacts
This review identified several barriers to testing of contacts. These barriers can be
categorized into four groups, including patient factors, provider factors, medical/technical
factors, and health system factors (Appendix Table A6).
These four barriers must be addressed because a single contact that has been
exposed and infected, yet not tested and evaluated, can develop active TB disease at some
point in his or her life. A single index case can infect up to 10 to 15 contacts over the
course of a year (WHO, 2012) and can give rise to TB outbreaks.
The patient-related barriers have several explanations. Gaps in knowledge about
how TB is transmitted and why testing is important can lead to contacts not showing up
for testing. Misconceptions about transmission, such as the belief that TB occurs because
of sharing food and utensils, can give rise to stigma (Collins et al., 2003; Faccini et al.,
2015; Fox et al., 2014; Kiter et al., 2003; Kwon et al., 2014). Lack of knowledge about
the development of TB disease in the body (pathogenesis) can lead to the belief that
smoking tobacco increases the risk of developing TB (Chakhaia et al., 2014; Fox et al.,
2015). Moreover, poor communication between the patient and provider because of
language barriers among non-US-born populations creates difficulty in conveying correct
information. Ethical concerns regarding the harms of getting tested, confidentiality of
information, and/or a fear of getting deported play a role in testing of contacts (Dewan et
al., 2006; Fox et al., 2012; Kambali et al., 2015). Practical issues such as long distances
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between the home and clinic, difficulties in taking time off from work and school,
forgetting to attend scheduled appointments, and changing residences can influence
contacts’ adherence to testing (Anger et al., 2012; Fox, et al., 2015; Gounder et al., 2014).
Evidence has shown that gaps in providers’ knowledge about TB contribute to
suboptimal care (Dresser et al., 2012). If providers do not consider TB as a possible
diagnosis, there will be a prolonged delay until a patient with TB is diagnosed and failure
to identify contacts until beyond 3 months after exposure. In addition, inappropriate
identification and selection of contacts can lead to an incomplete CI (Cates et al., 2015;
Chee et al., 2005; Davidow et al., 2003; Kambali et al., 2015; Marks et al., 2000;
Ratovoson et al., 2014; Wares et al., 2000; Yoshiyama et al., 2010). To acquire full
information from the index case during CI, it is critical for providers to establish trust and
rapport (Driver et al., 2003; Faccini et al., 2015; Marks et al., 2000). However, current
national and international guidelines lack guidance for staff involved in TB control on
how to establish rapport with cases during interviews. Nothing was found in the
literature about interviewing techniques or training interventions that can be used to
decrease feelings of stigma among cases and contacts (Anderson et al., 2014; Faccini et
al., 2015; Marks et al., 2000). In addition, providers with incomplete knowledge about
LTBI will not consider treatment for LTBI and therefore will not prevent TB from
becoming active (Chakhaia et al., 2014; Kettunen et al., 2007; Yun et al., 2003).
Furthermore, no studies were found that assessed the rates of TB testing based on the
type of provider. Most of the providers involved in CI are physicians, nurses, and
epidemiologists. However, after receiving basic training, lay workers also conduct TB
screening (Shah et al, 2013).
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Medical and technical factors are also potential barriers in CI. Contacts who are
immunocompromised because of HIV infection, malnutrition, or alcohol dependence,
which are considered co-morbidities of TB, have a much higher risk of developing TB
disease than contacts with normal immune systems. Their weakened immune system
may not respond to TB tests such as TST or IGRA (Bayona et al., 2003; Seddon et al.,
2013; Shapiro, 2013; Singh et al., 2005; Suggaravetsiri et al., 2003). The timing and
duration of exposure to MDR-TB are critical factors that require prompt results of drug
susceptibility tests of the index case; delays in obtaining results can result in ineffective
treatment and transmission of MDR-TB to contacts (Bayona et al., 2003; Seddon et al.,
2013). Technical factors such as the boosting effect of BCG vaccine and infection with
NTM can give rise to false-positive results on TST and cause misclassification of criteria
for transmission (Cates et al., 2015; Seddon et al., 2013). Thus, IGRA should be used
when testing contacts with a history of BCG vaccination (Diel et al., 2006; Zellweger et
al., 2015). In addition, IGRA is associated with better compliance because it does not
require a patient to come back for the test results, unlike TST. However, technical
procedures pertaining to IGRA can result in false-negative findings (Diel et al., 2006;
Zellweger et al., 2015). QuantiFERON-TB (QFT) is not sensitive enough to confirm true
LTBI (Diel et al., 2006), and neither is TST (Seddon et al., 2013). Therefore, to increase
the reliability and validity of TST, two-step testing should be applied, meaning that a
baseline TST is followed by another TST in 7 to 10 days (Chee et al., 2005; Collins et al.,
2003; Seddon et al., 2013).
Health systems from different countries employ various guidelines for CI
procedures depending upon the population and availability of resources. Most studies
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have restricted testing to contacts exposed to an index case with positive sputum smear
and culture. However, one study in this review concluded that transmission can still
occur among contacts who are exposed to an index case with negative sputum smear and
culture results. Therefore, contacts exposed to an index case with negative sputum smear
and culture but with TB symptoms should still be tested (Cates et al., 2015). Moreover,
there are no standard guidelines on CI regarding the number of persons exposed who
warrant CI. For example, contacts of index cases in correctional facilities who are to be
released within 6 months are not getting tested (Bur et al., 2003). In addition, workplaces
with fewer than 15 persons were not included in CI (Driver et al., 2003).
Finally, CI is labor-intensive and requires manpower. CI diverts staff members
from performing other TB activities such as managing cases of TB disease, which could
be more cost effective (Cates et al., 2015; Wares, et al., 2000). Because of limited
resources, CI is not always feasible. As mentioned before, TST and CXR are the most
commonly used tests in CI. However, guidelines on CI from Pacific Island countries
suggest not administering TST to contacts unless the National TB Program can offer 6
months of isoniazid therapy to TST-positive contacts and monitor them until completion
of treatment (Richard & Kerri, 2010). In the US, the guidelines on CI suggest employing
CXR only when the result of the TST is positive. Taking this US recommendation into
account could save resources in low-income countries (Atif et al., 2012). Guidelines
from the United Kingdom recommend the use of IGRA if the TST is positive (National
Institute of Health and Clinical Excellence, 2006). Recent US guidelines by the CDC
state that IGRA (QFT) can be used in all circumstances in which the TST is currently
used (BTBC, 2008; CDC, 2011; Mazurek et al., 2005).
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Evolving Role of Nurses Versus Public Health Advisors in NYC
In the literature search described, five qualitative studies were identified
(Appendix Table A7a) that support the role of nurses as case managers in TB control.
The primary role of nurses in TB control was to provide support for adherence to
treatment (medical management). In the mid-1990s, the nurses of the BTBC at DOHMH
Chest Clinics started case management of TB patients and became the primary clinician
responsible for index cases at the Chest Clinics, including contacts of index cases. The
nurses became involved in the risk assessment of contacts for testing and evaluation.
In 2012, a major change in the case management of TB cases was implemented
by the BTBC (Appendix Figure A1). The management of TB cases, including contacts
of the index cases at the Chest Clinics, was transferred back from TB nurse managers to
non-TB nurse managers, the Public Health Advisors (PHAs). A PHA is a public health
worker who assists with activities of the BTBC. The title was adopted by the BTBC
from the CDC workforce. The requirements to be appointed as a PHA include a
baccalaureate degree or a four-year high school diploma or its educational equivalent
approved by a State’s Department of Education, or experience on the basis of 30 semester
credits from an accredited college for one year of full-time experience. The PHA works
under the supervision of a higher-level PHA position.
PHA responsibilities have evolved over the years. In the early 1940, the initial
role of the PHA in the BTBC was mainly to assist in TB screening. In 1970s, the role of
the PHA in the BTBC was to locate contacts that had been exposed to a case of active TB
disease (index case). In the 1980s, the role of the PHA expanded to interviewing and
investigating contacts of an index case, including testing; returning the patient to medical
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care and follow-up; and performing chart review. In the early 1990s, after extensive
training to support their role, the PHAs started to review epidemiological data and
conduct health risk assessments of varying degrees of difficulty ranging from TB case
management to assisting supervisory personnel in the planning, organizing, and
conducting of disease control efforts in the BTBC. The PHA became the primary case
managers in the DOHMH Chest Clinics. However, in the mid-1990s, the PHA role was
changed to assisting nurses in the management of cases and focused more on finding
patients lost to follow-up and returning those patients back to medical care (BTBC,
1990). In 2012, because of the shortage of nurses, the PHA became the primary case
managers in the DOHMH Clinics (Appendix Table A7b).
Summary
To ensure the success of CI, TB control programs must identify barriers to testing
contacts and routinely evaluate the outcomes of CI (Fair et al., 2015). The literature
review described above identified wide variations in CI practices and several barriers to
effective CI due to knowledge gaps and other issues in countries worldwide. It is
therefore of interest to determine the impact of expanding PHA roles on TB case
management in the BTBC. Of the 35 quantitative studies included in the literature
review, only one study supported the role of lay workers (non-nurses) in CI who were
provided basic training (Shah, 2013). However, no studies were found that evaluated the
effectiveness of non-nurse TB case managers. This study is the first to examine the
proportion of contacts tested and evaluated based on type of provider.
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Chapter 3: Methods
Research Design
A retrospective case-control study design was conducted to explore the factors
associated with TB testing, evaluation, and treatment. This was an analysis of secondary
data from the NYC TB registry. The data is collected through routine case management
activities, and is entered in the TB registry by the case managers and other Bureau staff.
Contacts of active TB cases from 2010 to 2014 were identified and variables associated
with testing of contacts and evaluation was examined. Variables extracted from the TB
registry included demographics, contact information, reporting and assignment, clinical
disposition, and case management.
Study Site
The TB registry includes demographic, social, and clinical information on
individuals with confirmed active TB and with suspicion of disease, and their contacts.
The electronic registry allows the BTBC to generate statistics about the incidence and
prevalence of TB in NYC, report data to the CDC through the computerized system,
respond to clinicians’ questions about specific TB cases, and share epidemiologic
information with researchers both inside and outside the NYC Department of Health and
Mental Hygiene. Numerous quality assurance measures are put in place to ensure the
quality and integrity of data in the TB registry (BTBC, 1995).
In 2003, a computerized patient registration system was implemented in all Chest
Clinics; this system became an electronic medical record that allows more efficient
patient management and billing (BTBC, 2003).
Sample
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The study sample included all household contacts of New York confirmed cases
of active TB identified from 2010 to 2014; this included all household contacts who were
tested and those who were not tested and evaluated for TB (n=3,008). Non-household
contacts were excluded. A complete case analysis or listwise deletion was used to
address missing data. Thus, contacts that had missing information were removed from
the data analysis. The study sample includes demographic information and testing,
evaluation, and treatment information at three time points. For all household contacts,
gender, age, country of birth, race/ethnicity, and borough of residence are recorded. The
study sample also includes information about whether a household contact was tested for
TB, their TB test results, whether they were fully evaluated, and if they accepted or
refused LTBI treatment.
Measures
The outcomes that were measured are testing, evaluation, and treatment. The first
dependent variable is testing. Testing is the act of accepting the TB test, therefore, it
measures a person tested for TB. This is a binary (0/1) variable, 1= Tested (post
window); 0=Not tested. The second dependent variable is the result of the test for TB.
The results of the TB test are whether a person tests positive or negative for TB. This is a
binary (0/1) variable, 1 = positive TB test result (post-window); 0 = negative TB test
result (post-window). The third dependent variable is evaluation. Evaluation is when a
person with a positive result on TB testing accepts evaluation that include a chest x-ray
and assessment TB signs and symptoms, therefore, it measures a person who was
evaluated among those tested with a positive result. This is a binary (0/1) variable,
1=Evaluated; 0= Not evaluated. The fourth dependent variable is whether a contact
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accepted/completed LTBI treatment. This is a binary (0/1) variable, 1 = did not accept
LTBI treatment; 0 = accepted/completed LTBI treatment. The fifth dependent variable is
whether a contact refused LTBI treatment. This is a binary (0/1) variable, 1 = Did not
refuse LTBI treatment; 0 = Refused LTBI treatment.
Data Collection Plan
A research scientist staff member from the Surveillance and Epidemiology Unit
abstracted data from the TB registry and provided the de-identified data to the doctoral
student. This de-identified data was saved as the newly developed data set for analysis.
No separate tool was needed to reorganize the existing data from the TB registry.
Data Analysis
In order to explore the factors that are associated with TB testing, evaluation, and
treatment among household contacts, data were tested by estimating a logistic multi-level
model for each of the five dependent variables on TB testing, evaluation, and treatment.
The logistic multi-level models and bivariate statistics were run in R. The logistic multilevel models allowed the researcher to assess the impact of the independent variables on
the outcome, the relative impact of each independent variable by refitting the model
adding each independent variable incrementally, the potential collinearity among these
variables by exploring for effect of the independent variables controlling for potential
confounding between the independent variables, and any changes in testing and
evaluation effects. The variation inflation factor (VIF) was used to check for collinearity.
The VIF number indicates how much larger the error for the unique effect of a predictor.
Ideally scores should be below 2. The odds ratio, which is derived from the log odds
estimate of the multi-level model, is reported and interpreted. 95% confidence intervals
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are computed for the odds ratio and interpreted to compare the significance of the effect
between the predictor variables, and to compare the impact of incrementally adding
demographic variables to determine if the independent variables are confounds of each
other. At each time point, the full model, with all independent variables (both significant
and non-significant predictors) is interpreted and discussed. This tells the researcher
about the relative effect of each independent variable in predicting the outcome at each
time point.
The independent variables that was derived from the TB registry and included in
the analysis are: gender, age, country of birth, race/ethnicity, and borough of residence.
Age group was binned into minors, adults aged 18-44, middle-aged adults aged 45-64,
and senior adults aged 65 and older. Country of birth is grouped into two categories:
those born in the US and those born outside of the US. Race/Ethnicity was grouped into
the categories: non-Hispanic Black, Hispanic of any race, Asian, non-Hispanic White,
and Other including those identified with 2 or more racial or ethnic groups. Borough of
residence is one of the 5 boroughs in the City of New York: the Bronx, Brooklyn,
Manhattan, Queens, and Staten Island.
Descriptive analysis was used to identify factors associated with testing and
evaluation. The independent variables included in the analysis are categorical, so
proportions and frequency counts were calculated and presented. Prior to multivariate
analyses, bivariate analyses are presented separately in order to explore the effect of the
demographic variables on the outcome without controlling for the other independent
variables. Group comparisons of categorical variables were made using Pearson’s chisquare (χ2) tests at each time point. The Pearson’s chi-square test tells the researcher if
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there is a significant relationship between the group level variable and the outcome
variable. A significant relationship means that the outcomes at the different time points
were significantly different between the different levels of the group; the groups were
behaving differently from each other in terms of the outcome variable. The row
percentages reflect relative odds of each group level within an independent variable,
which controls for different number of household contacts in each group, and were
interpreted in line with the results of the logistic multi-level models.
Lastly, the results of the bivariate and multivariate statistics were compared to
show the changes in importance of each independent variable as a predictor of the
dependent variable when controlling for the other variables. Analysis of this secondary
data was not predefined and not part of primary research, therefore, there was no need to
adjust for multiplicity of comparison (Guowei et al., 2016).
Note that to explore the effect of type of provider (nurse vs. PHA) on whether
household contacts were tested and evaluated, Pearson’s chi-square tests with Yates'
continuity correction were run and interpreted. This analysis examined the effect of a
nurse vs. PHA on the outcomes of TB testing and evaluation by comparing data from
September 2010 through July 2012 when nurses were the primary case managers to data
from July 2012 through December 2014 when PHAs were the primary case managers.
Protection of Human Subjects
All analyses for this study consisted of de-identified data that were reported only
in aggregate form. Study procedures were evaluated by the Institutional Review Board of
the NYC DOHMH. Then following approval, the City University of New York Human
Research Protection Program reviewed the proposed study procedures.
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Limitation of Analysis of Secondary Data
The TB registry consists of data collected for program evaluation and is not
intended for research purposes; therefore, it does not capture all information necessary to
conduct a comprehensive analysis about CI.
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Chapter 4: Results
The primary purpose of the proposed study was to identify factors associated with
household contacts’ TB testing and evaluation between 2010 and 2014. Getting
household contacts to accept testing and evaluation is challenging because household
contacts do not manifest symptoms of active TB disease. In 2016, of the 565 index
(those with confirmed active TB) cases reported to the NYC Department of Health, the
total number of contacts (household and non-household) identified was 3,595, of which
2,716 (76%) were tested and evaluated (Chorba, 2016). In order to improve this rate in
NYC and potentially nationally, data from the NYC Bureau of Tuberculosis Control TB
registry between 2010 and 2014 was examined on potential demographic factors
influencing testing and evaluation rates.
The secondary purpose was to evaluate the proportion of contacts tested and
evaluated by nurse managers versus Public Health Advisors (PHAs) by comparing
household contacts tested and evaluated from January 2010 through - June 2012, when
nurses were the primary case managers and from July 2012 through - December 2014
when the primary case managers were PHAs. To determine the impact of expanding
PHA roles to TB case management in the BTBC, the proposed study examined the
proportion of contacts tested and evaluated based on type of provider.
Sample Size
Following identification of contacts there are three points in which household
contacts may not comply with the established protocol for testing and evaluation:
1. Tested or Not Tested for TB
2. Fully Evaluated and Not Fully Evaluated (among those who test positive for TB)
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3. Acceptance/Completed or Refused LTBI Treatment
Figure 1 presents the flow of the 3,008 household contacts through these three
points. First, among the 3,008, 2,850 (94.75%) household contacts were tested and of
these 2,850, 38.25% (1,090) of contacts tested positive for TB. Second, of the 1,090
contacts with positive TB tests 95.14% (1,037) were fully evaluated. Of the 53 not fully
evaluated, 33 refused to be fully evaluated, 20 others died, moved, or were lost prior to
evaluation. Of the 1,037 that were fully evaluated, 174 (16.8%) were deemed by the
physician as not infected, had a prior positive on TB test, not in need of treatment or were
administratively closed since they were unable to be found or moved out of the NYC
area. Third, the remaining 863 were offered treatment for latent TB infection, and
76.13% (657) accepted and completed treatment, while 28.87% (206) refused treatment.
Thus, of the 3,008, we are not certain of the TB status of 158 cases, and among the 1,090
contacts with a positive TB test, 206 refused LTBI treatment after a full evaluation and an
additional 53 refused or were lost to follow-up, moved or died without receiving a full
evaluation. Since cases are lost at each time point, the characteristics of testing,
evaluation, and treatment are presented separately.
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Figure 1. Household contacts’ testing & evaluation flow chart.

Overall Sample Characteristics
Table 1 provides the overall characteristics of household contacts from 2010
through 2014. The data was examined for the following demographics: gender, age
group, country of birth, race/ethnicity and borough residence of contacts. Among the
household contacts, the proportion of male (49.63%, n=1493) and female (50.37%,
n=1515) were almost equal. The plurality of household contacts by age group were
adults 18-44 (43.95%, n=1322). Over a quarter of household contacts were younger than
18 years old (28.76%, n=865). A little more than one-in-five household contacts were
middle-aged adults 45-64 (21.28%, n=640) and the smaller age group was seniors 65
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years old and older (6.02%, n=181). The majority, approximately two-thirds, of
household contacts were born outside of the USA (66.56%, n=2002). The largest
proportion of household contacts reported Asian race/ethnicity (39.06%, n=1175),
followed by Hispanic household contacts (32.21%, n=969). Nearly one-in-five household
contacts self-reported their ethnicity/race as non-Hispanic Black (19.38%, n=583). The
smallest proportions of ethnicity/racial categories self-reported non-Hispanic White
(5.85%, n=176) and Other (3.49%, n=105). The plurality of household contacts lived in
the borough of Queens (43.58%, n=1311). Nearly one-third of household contacts lived
in Brooklyn (31.05%, n=934). The remaining quarter of household contacts lived in the
Bronx (16.02%, n=482), Manhattan (7.18%, n=216), and Staten Island (2.16%, n=65).
Overall, most household contacts were adults 18-44 years of age, non-US born, Asian or
Hispanic, and residing in Queens or Brooklyn.
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Table 1. Demographic Characteristics of All Household Contacts of Active TB Cases
(n=3,008)
Demographics

Frequency Percentage
N=3,008

Gender
Male
Female

1,493
1,515

49.63
50.37

0-17
18-44
45-64
65+
Country of Birth
US-Born
Non-US Born
Race/Ethnicity
Non-Hispanic Black
Hispanic
Asian
Non-Hispanic White
Other
Borough
Bronx
Brooklyn
Manhattan
Queens
Staten Island

865
1,322
640
181

28.76
43.95
21.28
6.02

1,006
2,002

33.44
66.56

583
969
1,175
176
105

19.38
32.21
39.06
5.85
3.49

482
934
216
1,311
65

16.02
31.05
7.18
43.58
2.16

Age-Group

Sample Characteristics at Three Time Points
Chi-squared tests of independence were calculated comparing the frequencies of
behaviors of household contacts at different time points. This was done to determine
whether behaviors of household contacts at different time points were related to
demographic variables of age, gender, country of origin, race/ethnicity, and borough of
residence. Responses for different time points were analyzed separately.
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Behaviors of household contacts at different time points are presented first
regardless of demographic variables. Probability (p) values less than 0.05 (p < .05) are
considered to be significant. If a significant relation exists between a demographic
variable and behaviors of household contacts at different time points, behaviors of
household contacts at different time points are further reported by demographic variables.
Only contingency tables are showed for variables that approached significance (p<.10)
result and interpreted.

Tested and Not Tested
Among the N=3,008 household contacts, the vast majority (94.75%, n=2850) of
household contacts were tested for TB and only about one-in-twenty (5.25%, n=158)
were not tested for TB.
The proportion of household contacts being tested did not significantly differ by
gender group, in Table 2. A chi-squared test of independence looking at the relationship
between testing by gender (χ2(1)=0.44, p=0.51) was not significant.

Table 2. Demographic Characteristics of Household Contacts Tested/Not Tested for
by Gender

Male
Female
Total

Tested

Not Tested Total

1,410

83 1,493

94.44%

5.56%

1,440

75

95.05%

4.95%

2,850
94.75%

1515

158 3,008
5.25%
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The proportion of household contacts being tested significantly differed by age
group, in Table 3. A chi-squared test of independence looking at the relationship between
testing by age group (χ2(3)=39.09, p<.001) was significant. A much higher proportion of
household contacts that were 0-17 years old (98.73%, n=854) were tested for TB
compared to the other age groups. Household contacts 45 years old older were less likely
to be tested (45-64 years old: 92.97%, n=595, 65 years and older: 92.27%, n=167).

Table 3. Demographic Characteristics of Household Contacts Tested/Not Tested for
by Age Group
Tested
0-17
18-44
45-64
65+
Total

Not Tested Total

854

11

98.73%

1.27%

1,234

88 1,322

93.34%

6.66%

595

45

92.97%

7.03%

167

14

92.27%

7.73%

2,850
94.75%

865

640
181

158 3,008
5.25%

The proportion of household contacts being tested significantly differed by
country of birth, in Table 4. A chi-squared test of independence looking at the
relationship between testing by country of birth (χ2(1)=11.23, p<.001) was significant. A
lower proportion of household contacts that were not born in the US (93.76%, n=1877)
were tested for TB than the proportion of household contacts that were born in the US
(96.72%, n=973) that were tested for TB.
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Table 4. Demographic Characteristics of Household Contacts Tested/Not Tested for
by Country of Birth

US-Born

Tested

Not Tested Total

973

33 1,006

96.72%
Non-US-Born
Total

1,877

3.28%
125 2,002

93.76%

6.24%

2,850
94.75%

158 3,008
5.25%

The proportion of household contacts being tested significantly differed by
race/ethnicity, in Table 5. A chi-squared test of independence looking at the relationship
between testing by race/ethnicity (χ2(4)=11.47, p<.05) was significant. A lower
proportion of household contacts identified as Other (91.43%, n=96), Non-Hispanic
Black (93.14%, n=543), and Non-Hispanic White (92.05%, n=162) were tested for TB
than household contacts identified as Hispanic (95.15%, n=922) and Asian (95.91%,
n=1127).
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Table 5. Demographic Characteristics of Household Contacts Tested/Not Tested for
by Race/Ethnicity
Tested
Non-Hispanic Black
Hispanic
Asian
Non-Hispanic White
Other
Total

Not Tested Total

543

40

93.14%

6.86%

922

47

95.15%

4.85%

1,127

4.09%

162

14

92.05%

7.95%

96

9

91.43%

8.57%

94.75%

969

48 1,175

95.91%

2,850

583

176
105

158 3,008
5.25%

The proportion of household contacts being tested did not significantly differ by
borough, in Table 6. A chi-squared test of independence looking at the relationship
between testing by borough (χ2(4)=3.68, p=0.45) was not significant.
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Table 6. Demographic Characteristics of Household Contacts Tested/Not Tested for
by Borough
Tested
Bronx

Not Tested Total

459

23

95.23%

4.77%

888

46

95.07%

4.93%

206

10

95.37%

4.63%

Brooklyn
Manhattan
Queens

1,233

5.95%

64

1

98.46%

1.54%

Total

2,850
94.75%

934
216

78 1,311

94.05%
Staten Island

482

65

158 3,008
5.25%

Testing Positive and Testing Negative
Among the N=2850 household contacts tested, over one-third (38.25%, n=1090)
of household contacts tested positive for TB.
The proportion of household contacts that tested positive significantly differed by
gender, in Table 7. A chi-squared test of independence looking at the relationship
between testing positive by gender (χ2(1)=4.74, p<.05) was significant. A higher
proportion of males (40.28%, n=568) tested positive for TB than the proportion of
females (35.25%, n=522) that tested positive for TB.
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Table 7. Demographic Characteristics of Household Contacts Testing Positive
Versus Negative by Gender
Positive Negative Total
Male

568
40.28%

Female

522
36.25%

Total

1,090
38.25%

842 1,410
59.72%
918 1,440
63.75%
1760 2,850
61.75%

The proportion of household contacts that tested positive significantly differed by
age group, in Table 8. A chi-squared test of independence looking at the relationship
between testing positive by age group (χ2(3)=146.56, p<.001) was significant. The
highest proportion of household contacts testing positive for TB was in the 45-64 years
old age group where nearly half tested positive for TB (49.75%, n=296). The lowest
proportion of household contacts testing positive for TB was in the 0-17 years old age
group where only one-in-five tested positive for TB (21.90%, n=187).
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Table 8. Demographic Characteristics of Household Contacts Testing Positive
Versus Negative by Age Group
Positive Negative Total
0-17
18-44
45-64
65+
Total

187

667

21.90%

78.10%

528

706 1,234

42.79%

57.21%

296

299

49.75%

50.25%

79

88

47.31%

52.69%

1,090
38.25%

854

595
167

1,760 2,850
61.75%

The proportion of household contacts that tested positive significantly differed by
country of birth, in Table 9. A chi-squared test of independence looking at the
relationship between testing positive by country of birth group (χ2(1)=247.72, p<.001)
was significant. The highest proportion of household contacts testing positive for TB
were not born in the US where nearly half tested positive (48.59%, n=912). A much
lower proportion of household contacts that were born in the US tested positive for TB
where only about one-in-five tested positive for TB (18.29%, n=178).
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Table 9. Demographic Characteristics of Household Contacts Testing Positive
Versus Negative by Country of Birth
Positive Negative Total
US-Born
Non-US-Born

178

795

18.29%

81.71%

912
48.59%

Total

1,090
38.25

973

965 1,877
51.41%
1,760 2,850
61.75%

The proportion of household contacts that tested positive significantly differed by
race/ethnicity, in Table 10. A chi-squared test of independence looking at the relationship
between testing positive by race/ethnicity (χ2(4)=36.68, p<.001) was significant. More
than half (52.08%, n=50) of household contacts that identified as Other tested positive for
TB. This was a higher proportion of household contacts testing positive for TB than other
racial/ethnic groups. The second highest proportion of household contacts testing positive
for TB were those household contacts identified as Asian (42.15%, n=475). The lowest
proportion of household contacts testing positive for TB were identified as non-Hispanic
Black (29.28%, n=159) and non-Hispanic White (31.48%, n=51).
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Table 10. Demographic Characteristics of Household Contacts Testing Positive
Versus Negative by Race/Ethnicity
Positive Negative Total
Non-Hispanic Black
Hispanic
Asian
Non-Hispanic White
Other
Total

159

384

29.28%

70.72%

355

567

38.50%

61.50%

475

57.85%

51

111

31.48%

68.52%

50

46

52.08%

47.92%

38.25%

922

652 1,127

42.15%

1,090

543

162
96

1,760 2,850
61.75%

The proportion of household contacts that tested positive significantly differed by
borough, in Table 11. A chi-squared test of independence looking at the relationship
between testing positive by borough (χ2(4)=44.75, p<.001) was significant. The highest
proportion of household contacts testing positive for TB lived in Queens (43.23%,
n=533). The lowest proportion of household contacts testing positive for TB lived in the
Bronx (25.49%, n=117). Residents in Brooklyn (38.29%, n=340), Manhattan (36.89%,
n=76), and Staten Island (37.50%, n=24) had a similar proportion of household contacts
testing positive for TB.
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Table 11. Demographic Characteristics of Household Contacts Testing Positive
Versus Negative by Borough
Positive Negative Total
Bronx

117

342

25.49%

74.51%

340

548

38.29%

61.71%

76

130

36.89%

63.11%

Brooklyn
Manhattan
Queens

533

Total

56.77%

24

40

37.50%

62.50%

1,090
38.25%

888
206

700 1,233

43.23%
Staten Island

459

64

1,760 2,850
61.75%

Fully Evaluated vs Not Fully Evaluated
Among the N=1090 household contacts that tested positive for TB, the vast
majority (95.14%, n=1037) of household contacts were fully evaluated. Only one-intwenty (4.86%, n=53) household contacts were not fully evaluated.
The proportion of household contacts that were fully evaluated significantly
differed by gender, in Table 12. A chi-squared test of independence looking at the
relationship between undergoing evaluation by gender (χ2(1)=9.41, p<.01) was
significant. A higher proportion of females (97.32%, n=508) were fully evaluated
compared to the proportion of males (93.13%, n=529) that were fully evaluated.
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Table 12. Demographic Characteristics of Household Contacts Fully Evaluated
Versus Not Fully Evaluated by Gender
Fully

Not Fully

Evaluated Evaluated Total
Male
Female
Total

529

39

568

93.13%

6.87%

508

14

97.32%

2.68%

1,037
95.14%

53 1,090
4.86%

522

The proportion of household contacts that were fully evaluated significantly
differed by age group, in Table 13. A chi-squared test of independence looking at the
relationship between undergoing evaluation by age group (χ2(3)=10.63, p<.05) was
significant. Nearly all household contacts 0-17 years old (99.47%, n=186) were fully
evaluated. The lowest proportion of household contacts that were fully evaluated were
adults 18-44 years old (93.56%, n=494) followed by adults aged 45-64 (94.93%, n=281).
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Table 13. Demographic Characteristics of Household Contacts Fully Evaluated
Versus Not Fully Evaluated by Age Group
Fully

Not Fully

Evaluated Evaluated Total
0-17
18-44
45-64
65+
Total

186

1

99.47%

0.53%

494

34

93.56%

6.44%

281

15

94.93%

5.07%

76

3

96.20%

3.80%

1,037
95.14%

187
528
296
79

53 1,090
4.86%

The proportion of household contacts that were fully evaluated significantly
differed by country of birth, in Table 14. A chi-squared test of independence looking at
the relationship between undergoing evaluation by country of birth (χ2(1)=9.65, p<.01)
was significant. All individuals born in the US were fully evaluated (100.00%, n=178)
whereas nearly a majority were fully evaluated (94.19%, n=859) that were born outside
of the US.
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Table 14. Demographic Characteristics of Household Contacts Fully Evaluated
Versus Not Fully Evaluated by Country of Birth
Fully

Not Fully

Evaluated Evaluated Total
US-Born
Non-US-Born
Total

178

0

100.00%

0.00%

859

53

94.19%

5.81%

1,037
95.14%

178
912

53 1,090
4.86%

The proportion of household contacts that were fully evaluated did not
significantly differ by race/ethnicity, in Table 15. A chi-squared test of independence
looking at the relationship between undergoing evaluation by gender (χ2(4)=2.42,
p=0.66) was not significant.
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Table 15. Demographic Characteristics of Household Contacts Fully Evaluated
Versus Not Fully Evaluated by Race/Ethnicity
Fully

Not Fully

Evaluated Evaluated Total
Non-Hispanic Black
Hispanic
Asian
Non-Hispanic White
Other
Total

153

6

159

96.23%

3.77%

335

20

94.37%

5.63%

455

20

95.79%

4.21%

47

4

92.16%

7.84%

47

3

94.00%

6.00%

1,037
95.14%

53 1,090
4.86%

355
475
51
50

The proportion of household contacts that were fully evaluated significantly
differed by borough, in Table 16. A chi-squared test of independence looking at the
relationship between undergoing evaluation by borough (χ2(4)=10.10, p<.05) was
significant. All household contacts were fully evaluated that lived in Staten Island
(100.00%, n=24) and nearly all household contacts were fully evaluated that lived in
Brooklyn (97.65%, n=332). The lowest proportion of household contacts that were fully
evaluated lived in Manhattan (92.11%, n=70) and Queens (93.62%, n=499).
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Table 16. Demographic Characteristics of Household Contacts Fully Evaluated
Versus Not Fully Evaluated by Borough
Fully

Not Fully

Evaluated Evaluated Total
Bronx

112

5

95.73%

4.27%

332

8

97.65%

2.35%

70

6

92.11%

7.89%

499

34

93.62%

6.38%

24

0

100.00%

0.00%

Brooklyn
Manhattan
Queens
Staten Island
Total

1,037
95.14%

117
340
76
533
24

53 1,090
4.86%

Accepted and Refused LTBI Treatment
Among the N=863 household contacts that were offered LTBI treatment, over
three-fourths (76.13%, n=657) of household contacts accepted and completed LTBI
treatment while less than a quarter of household contacts refused LTBI treatment
(23.87%, n=206).
The proportion of household contacts that accepted treatment did not significantly
differ by gender, in Table 17. A chi-squared test of independence looking at the
relationship between accepting LTBI treatment by gender (χ2(1)=0.01, p=0.91) was not
significant.
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Table 17. Demographic Characteristics of Household Contacts Accepted Versus
Refused LTBI Treatment by Gender
Accepted Refused Total
Male
Female
Total

324

100

76.42%

23.58%

333

106

75.85%

24.15%

657

206

76.13%

23.87%

424
439
863

The proportion of household contacts that accepted treatment significantly
differed by age group, in Table 18. A chi-squared test of independence looking at the
relationship between accepting treatment by age group (χ2(3)=45.22, p<.001) was
significant. Across age groups, the highest proportion accepted and completed LTBI
treatment among household contacts aged 0-17 (95.86%, n=162). A similar proportion of
household contacts accepted and completed LTBI treatment for age groups aged 18 and
above: 18-44 years old (71.96%, n=290), 45-64 years old (70.51%, n=165), 65+ years old
(70.18%, n=40).
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Table 18. Demographic Characteristics of Household Contacts Accepted Versus
Refused LTBI Treatment by Age Group
Accepted Refused Total
0-17
18-44
45-64
65+
Total

162

7

95.86%

4.14%

290

113

71.96%

28.04%

165

69

70.51%

29.49%

40

17

70.18%

29.82%

657

206

76.13%

23.87%

169
403
234
57
863

The proportion of household contacts that accepted treatment significantly
differed by country of birth, in Table 19. A chi-squared test of independence looking at
the relationship between accepting treatment by country of birth (χ2(1)=19.53, p<.001)
was significant. A higher proportion accepted and completed LTBI treatment among
household contacts born in the US (89.94%, n=143) than among household contacts born
outside the US (73.01%, n=514).
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Table 19. Demographic Characteristics of Household Contacts Accepted Versus
Refused LTBI Treatment by Country of Birth
Accepted Refused Total
US-Born
Non-US-Born
Total

143

16

89.94%

10.06%

514

190

73.01%

26.99%

657

206

76.13%

23.87%

159
704
863

The proportion of household contacts that accepted treatment significantly
differed by race/ethnicity, in Table 20. A chi-squared test of independence looking at the
relationship between accepting treatment by race/ethnicity (χ2(4)=17.88, p<.001) was
significant. Across race/ethnicity, the highest proportion of household contacts that
accepted and completed LTBI treatment identified as Hispanic (84.21%, n=224). The
lowest proportion of household contacts that accepted and completed LTBI treatment
identified as non-Hispanic White (62.16%, n=23). Nearly three-quarters of household
contacts identifies as Asian (74.23%, n=291) and identified as non-Hispanic Black
(72.66%, n=93) accepted and completed LTBI treatment.
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Table 20. Demographic Characteristics of Household Contacts Accepted Versus
Refused LTBI Treatment by Race/Ethnicity
Accepted Refused Total
Non-Hispanic Black
Hispanic
Asian
Non-Hispanic White
Other
Total

93

35

72.66%

27.34%

224

42

84.21%

15.79%

291

101

74.23%

25.77%

23

14

62.16%

37.84%

26

14

65.00%

35.00%

657

206

76.13%

23.87%

128
266
392
37
40
863

The proportion of household contacts that accepted treatment significantly
differed by borough, in Table 21. A chi-squared test of independence looking at the
relationship between accepting treatment by borough (χ2(4)=16.73, p<.01) was
significant. Across borough, the highest proportion of household contacts that accepted
and completed LTBI treatment lived in the Bronx (92.05%, n=81). The lowest proportion
of household contacts that accepted and completed LTBI treatment lived in Brooklyn
(71.28%, n=206), Staten Island (71.43%, n=15), or Manhattan (72.55%, n=37). Over
three-quarters of household contacts that lived in Queens (76.81%, n=318) accepted and
completed LTBI treatment.
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Table 21. Demographic Characteristics of Household Contacts Accepted Versus
Refused LTBI Treatment by Borough
Accepted Refused Total
Bronx
Brooklyn
Manhattan
Queens
Staten Island
Total

81

7

92.05%

7.95%

206

83

71.28%

28.72%

37

14

72.55%

27.45%

318

96

76.81%

23.19%

15

6

71.43%

28.57%

657

206

76.13%

23.87%

88
289
51
414
21
863

Household Contacts Tested, Fully Evaluated, and Accepted/Completed LTBI
treatment between Two Periods from September 2010-July 2012 and July 2012December 2014
To address the secondary aim, which is to evaluate the proportion of contacts
tested and evaluated based on type of provider, difference in outcomes at the three points
(TB testing, full evaluation, and LTBI treatment) were compared based on two time
periods. During the first time period September 2010 through June 2012, nurses were the
primary case managers while those in the second time period, July 2012 through
December 2014, PHAs were the primary case managers.
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The proportion of household contacts being tested did not significantly differ by
time period, in Table 22. A chi-squared test of independence looking at the relationship
between testing by time period (χ2(1)=0.21, p=0.65) was not significant.

Table 22. Household Tested Treatment Between September 2010-July 2012 Versus
July 2012-December 2014

Sept. 2010-June 2012

Tested

Not Tested Total

1,220

62 1,282

95.16%
July 2012-Dec. 2014

1,630
94.44%

Total

2,850
94.75%

4.84%
96 1,726
5.56%
158 3,008
5.25%

The proportion of household contacts that tested positive significantly differed by
time period, in Table 23. A chi-squared test of independence looking at the relationship
between TB results by time period (χ2(1)=28.81, p<.001) was significant. A lower
proportion of household contacts that were tested for TB tested positive in July 2012December 2014 (33.99%, n=554) than household contacts that were tested for TB and
tested positive in September 2010-June 2012 (43.93%, n=536).
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Table 23. TB Results Between September 2010-July 2012 Versus July 2012December 2014
Positive Negative Total
Sept. 2010-June 2012 536
July 2012-Dec. 2014
Total

684

43.93%

56.07%

554

1,076

33.99%

66.01%

1,090

1,760

38.25%

61.75%

1,220
1,630
2,850

The proportion of household contacts that were fully evaluated did not
significantly differ by time period, in Table 24. A chi-squared test of independence
looking at the relationship between evaluation by time period (χ2(1)=2.35, p=0.13) was
not significant.

Table 24. Fully Evaluated Between September 2010-July 2012 Versus July 2012December 2014
Fully

Not Fully

Evaluated Evaluated Total
Sept. 2010-June 2012 504
July 2012-Dec. 2014
Total

32

94.03%

5.97%

533

21

96.21%

3.79%

1,037

53

95.14%

4.86%

536
554
1,090

The proportion of household contacts that accepted treatment did not significantly
differ by time period, in Table 25. A chi-squared test of independence looking at the
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relationship between treatment by time period (χ2(1)=1.90, p=0.17) was not significant.
A higher proportion of household contacts that were fully evaluated, accepted treatment
in July 2012-December 2014 (78.15%, n=354) than household contacts that were fully
evaluated and accepted treatment in September 2010-June 2012 (73.90%, n=303).

Table 25. LTBI Treatment Between September 2010-July 2012 Versus July 2012December 2014
Accepted Refused Total
Sept. 2010-June 2012 303
July 2012-Dec. 2014
Total

107

73.90%

26.10%

354

99

78.15%

21.85%

657

206

76.13%

23.87%

410
453
863

Appendix Tables A8-A13 provide a summary of all univariate analyses.
Multivariate Analyses
Logistic regression was used to analyze predictor variables (demographic
characteristics) associated with the three outcome variables at three time points: TB
testing, full evaluation, and LTBI treatment.
The logistic regressions are used to examine the effects of multiple variables on
the outcome variable and isolate each individual variable’s effect on the outcome variable
while controlling for the others. Interpretation of the statistical results and a discussion of
them as they relate to the hypotheses will follow.

TB Testing
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The factors impacting likelihood of a household contact being tested for TB are
explored. Logistic regression models were fit to the data to see if age group, country of
birth, race/ethnicity, and borough of residence impacted likelihood of a household contact
being tested for TB and to explore how these variables interact.
As illustrated in Table 26, age is the only demographic characteristic that was
found to be significant predictors of accepting TB testing after controlling for all other
variables. The following explains the stepwise logistic regression models.
Model 1 – Age
A model was fit to the data which looked at the household contact age as a
predictor of whether the household contact was tested or not for TB. The model was a
significantly better fit than a model which did not include age as a predictor variable,

χ2(3)=41.18, p<.001.
Age group was a significant predictor of whether a household contact would be
tested for TB. Household contacts aged 18-44 are significantly less likely to be tested
than household contacts younger than 18 are to be tested for TB, β=-1.86, SE(β)=0.40,
z=-4.65, p<.001. They are 0.16 times (OR 95% CI: 0.07, 0.34) as likely to be tested than
minors. Household contacts aged 45-64 are significantly less likely to be tested than
household contacts less than 18 are to be tested for TB, β=-1.96, SE(β)=0.42, z=-4.69,
p<.001. They are 0.14 times (OR 95% CI: 0.06, 0.32) as likely to be tested than minors.
Household contacts aged 65+ are significantly less likely to be tested than household
contacts less than 18 are to be tested for TB, β=-2.01, SE(β)=0.49, z=-4.09, p<.001. They
are 0.13 times (OR 95% CI: 0.05, 0.35) as likely to be tested than minors.
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Therefore, age is a significant predictor of TB testing. Adult household contacts
are significantly less likely to be tested than minors. The older the person, the less likely
tested.

Model 2 – Country of Birth
A second model was fit to the data which looked at the household contact country
of birth as a predictor of whether the household contact was tested or not for TB in
addition to the variables in model 1. The model was not a significantly better fit than a
model which did not include country of birth as a predictor variable, χ2(1)=0.32, p=.86.
Country of birth was not a significant predictor of whether a household contact was tested
or not for TB, controlling for age.

Model 3 – Race/Ethnicity
A third model was fit to the data which looked at the household contact
race/ethnicity as a predictor of whether the household contact was tested or not for TB in
addition to the variables in model 2. The model was not a significantly better fit than a
model which did not include race/ethnicity as a predictor variable, χ2(4)=5.29, p=.26.
Race/Ethnicity was not a significant predictor of whether a household contact was tested
or not for TB, controlling for age, and country of birth.

Model 4 – Borough (Full Model)
A fourth model was fit to the data which looked at the household contact borough
of residence as a predictor of whether the household contact was tested or not for TB in
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addition to the variables in model 4. The model was not a significantly better fit than a
model which did not include borough of residence as a predictor variable, χ2(4)=3.41,
p=.49. Borough of residence was not a significant predictor of whether a household
contact was tested or not for TB, controlling for age, country of birth, and Race/Ethnicity.
However, the full model with age, country of birth, race/ethnicity, and borough of
residence was a significantly better fit than the null intercept-only model, χ2(12)=49.91,
p=<.001.
Age group was a significant predictor of whether a household contact would be
tested for TB. Household contacts aged 18-44 are significantly less likely to be tested
than household contacts younger than 18 are to be tested for TB, β=-1.77, SE(β)=0.44,
z=-4.04, p<.001. They are 0.17 times (OR 95% CI: 0.07, 0.38) as likely to be tested than
minors. Household contacts aged 45-64 are significantly less likely to be tested than
household contacts less than 18 are to be tested for TB, β=-1.87, SE(β)=0.46, z=-4.06,
p<.001. They are 0.15 times (OR 95% CI: 0.06, 0.36) as likely to be tested than minors.
Household contacts aged 65+ are significantly less to be likely tested than household
contacts less than 18 are to be tested for TB, β=-1.95, SE(β)=0.53, z=-3.66, p<.001. They
are 0.14 times (OR 95% CI: 0.05, 0.40) as likely to be tested than minors.
Although household contacts born outside the US are less likely to be tested than
household contacts born in the US (β=-0.17, SE(β)=0.29, z=-0.58, p=.56), this difference
was not significant.
Race was not a significant predictor of whether a household contact would be
tested. Household contacts that identified as Asian were more likely to be tested than
household contacts that identified as White (β=0.67, SE(β)=0.38, z=1.75, p=.08) although
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this difference only approached significance. Household contacts that identified as Asian
are 1.95 times (OR 95% CI: 0.88, 4.00) more likely tested than household contacts that
identified as White. Although household contacts that identified as Black were slightly
more likely to be tested than household contacts that identified as White (β=0.08,
SE(β)=0.39, z=0.21, p=.83), this difference was not significant. Although household
contacts that identified as Hispanic were slightly more likely to be tested than household
contacts that identified as White (β=0.47, SE(β)=0.39, z=1.22, p=.22), this difference was
not significant. Although household contacts that identified as Other race were slightly
more likely to be tested than household contacts that identified as White (β=0.07,
SE(β)=0.53, z=0.14, p=.89), this difference was not significant.
Borough of residence was not a significant predictor of whether a household
contact would be tested. Although household contacts that lived in Brooklyn were
slightly more likely to be tested than household contacts that lived in the Bronx (β=0.09,
SE(β)=0.31, z=0.30, p=.76), this difference was not significant. Although household
contacts that lived in Manhattan were slightly more likely to be tested than household
contacts that lived in the Bronx (β=0.21, SE(β)=0.46, z=0.45, p=.65), this difference was
not significant. Although household contacts that lived in Queens were slightly less likely
to be tested than household contacts that lived in the Bronx (β=-0.23, SE(β)=0.29, z=0.81, p=.42), this difference was not significant. Although household contacts that lived
in Staten Island were slightly more likely to be tested than household contacts that lived
in the Bronx (β=0.75, SE(β)=1.05, z=0.71, p=.48), this difference was not significant.
Therefore, non-US born, race/ethnicity & borough did not affect the age of the
household contacts tested for TB.
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Table 26. Demographic Characteristics Associated with TB Testing (Beta
Coefficient and Standard Error in Parentheses)
===============================================================
Dependent Variable: Tested vs Not Tested
Model

(1)

(2)

(3)

(4)

Independent Variable:
- ---------------------------------------------------------------------------------------------------------Age Group
0-17 (Reference)
18-44
-1.863***
-1.832***
-1.752***
-1.768***
(0.400)
(0.436)
(0.436)
(0.438)
45-64

-1.958***
(0.418)

-1.924***
(0.459)

-1.843***
(0.459)

-1.869***
(0.461)

65+

-2.014***
(0.493)

-1.979***
(0.531)

-1.926***
(0.531)

-1.954***
(0.534)

-0.048
(0.273)

-0.209
(0.284)

-0.166
(0.286)

0.539
(0.374)

0.669*
(0.383)

Black

0.053
(0.388)

0.083
(0.391)

Hispanic

0.361
(0.378)

0.475
(0.389)

Other

-0.115
(0.522)

0.074
(0.533)

Country of Birth
US Born (Reference)
Non-US born

Race/Ethnicity
White (Reference)
Asian

Borough
Bronx (Reference)
Brooklyn

Manhattan

0.093
(0.306)
0.208

62
(0.462)
Queens

-0.234
(0.288)

Staten Is

0.748
(1.052)

Constant

4.484***
(0.380)

4.493***
(0.384)

4.232***
(0.497)

4.178***
(0.553)

-----------------------------------------------------------------------------------------------------------Observations
2,257
2,257
2,257
2,257
Log Likelihood
-454.020
-454.004
-451.358
-449.655
Akaike Inf. Crit.
916.039
918.008
920.717
925.311
===============================================================
Note:
*p<0.1; **p<0.05; ***p<0.01

TB Results: Positive or Negative
The factors impacting likelihood of a household contact testing positive for TB
are explored. Logistic regression models were fit to the data to see if age group, country
of birth, race/ethnicity, and borough of residence impacted likelihood of a household
contact testing positive for TB and to explore how these variables interact.
Three demographic variables were found to be significant predictors of TB test
positive, after controlling for all other variables in the model: age-group, non-US born,
and borough. As illustrated in Table 27, the only demographic characteristic that was
found to be significant predictors of TB test positive vs TB test negative after controlling
for all other variables are age, non-US born, and borough. The following explains the
stepwise logistic regression models.

Model 1 – Age
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A model was fit to the data which looked at the household contact age as a
predictor of whether the household contact test positive for TB. The model was a
significantly better fit than a model which did not include age as a predictor variable,

χ2(3)=125.19, p<.001.
Age group was a significant predictor of whether a household contact would test
positive for TB. Household contacts aged 18-44 are significantly more likely to test
positive for TB than household contacts younger than 18 are to test positive for TB,
β=0.98, SE(β)=0.11, z=8.69, p<.001. They are 2.66 times (OR 95% CI: 2.15, 3.3) as
likely to test positive for TB than minors. Household contacts aged 45-64 are
significantly more likely to test positive than household contacts less than 18 are to test
positive for TB, β=1.25, SE(β)=0.13, z=9.56, p<.001. They are 3.49 times (OR 95% CI:
2.7, 4.5) as likely to test positive for TB than minors. Household contacts aged 65+ are
significantly more likely to test positive than household contacts less than 18 are to test
positive for TB, β=1.35, SE(β)=0.19, z=6.98, p<.001. They are 3.86 times (OR 95% CI:
2.66, 5.6) as likely to test positive for TB than minors.
Therefore, age is associated with having a TB test positive. The older the person,
the more likely for a person to have a TB test positive.

Model 2 – Country of Birth
A second model was fit to the data which looked at the household contact country
of birth as a predictor of whether the household contact test positive for TB in addition to
the variables in model 1. The model was a significantly better fit than a model which did
not include country of birth as a predictor variable, χ2(1)=78.19, p<.001.
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Age group residence was a significant predictor of whether a household contact
would test positive for TB. Household contacts aged 18-44 are significantly more likely
to test positive for TB than household contacts younger than 18 are to test positive for
TB, β=0.31, SE(β)=0.14, z=2.23, p<.05. They are 1.36 times (OR 95% CI: 0.94, 1.98) as
likely to test positive for TB than minors. Household contacts aged 45-64 are
significantly more likely to test positive than household contacts less than 18 are to test
positive for TB, β=0.51, SE(β)=0.16, z=3.28, p<.01. They are 1.67 times (OR 95% CI:
1.22, 2.28) as likely to test positive for TB than minors. Household contacts aged 65+ are
significantly more likely to test positive than household contacts less than 18 are to test
positive for TB, β=0.59, SE(β)=0.21, z=2.77, p<.01. They are 1.8 times (OR 95% CI:
1.20, 2.72) as likely to test positive for TB than minors.
Country of birth was a significant predictor of whether a household contact would
test positive for TB. Household contacts born outside of the US were significantly more
likely to test positive for TB than household contacts born in the US, β=1.11, SE(β)=0.13,
z=8.59, p<.001. They are 3.03 times (OR 95% CI: 2.35, 3.91) as likely to test positive for
TB than household contacts born in the US.

Model 3 – Race/Ethnicity
A third model was fit to the data which looked at the household contact
race/ethnicity as a predictor of whether the household contact test positive for TB in
addition to the variables in model 2. The model was not a significantly better fit than a
model which did not include race/ethnicity as a predictor variable, χ2(4)=5.76, p=.22.
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Race/Ethnicity was not a significant predictor of whether a household contact test
positive for TB, controlling for age, and country of birth.

Model 4 – Borough
A fourth model was fit to the data which looked at the household contact borough
of residence as a predictor of whether the household contact test positive for TB in
addition to the variables in model 4. The model was a significantly better fit than a model
which did not include borough of residence as a predictor variable, χ2(4)=20.97, p<.001.
Age group of household contact was a significant predictor of whether a
household contact would test positive for TB. Household contacts aged 18-44 are
significantly more likely to test positive for TB than household contacts younger than 18
are to test positive for TB, β=0.31, SE(β)=0.14, z=2.23, p<.05. They are 1.36 times (OR
95% CI: 1.04, 1.79) as likely to test positive for TB than minors. Household contacts
aged 45-64 are significantly more likely to test positive than household contacts less than
18 are to test positive for TB, β=0.53, SE(β)=0.16, z=3.35, p<.001. They are 1.7 times
(OR 95% CI: 1.24, 2.32 ) as likely to test positive for TB than minors. Household
contacts aged 65+ are significantly more likely to test positive than household contacts
less than 18 are to test positive for TB, β=0.64, SE(β)=0.22, z=2.95, p<.01. They are 1.9
times (OR 95% CI: 1.23, 2.92) as likely to test positive for TB than minors.
Country of birth residence was a significant predictor of whether a household
contact would test positive for TB. Household contacts born outside of the US were
significantly more likely to test positive for TB than household contacts born in the US,
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β=1.09, SE(β)=0.13, z=8.16, p<.001. They are 2.97 times (OR 95% CI: 0.84, 3.84) as
likely to test positive for TB than household contacts born in the US.
Race/Ethnicity was not a significant predictor of whether a household contact
would test positive for TB. Although household contacts that identified as Asian were
slightly less likely to test positive for TB than household contacts that identified as White
(β=-0.06, SE(β)=0.20, z=-0.32, p=.75), this difference was not significant. Although
household contacts that identified as Black were slightly more likely to test positive for
TB than household contacts that identified as White (β=0.03, SE(β)=0.21, z=0.16, p=.87),
this difference was not significant. Although household contacts that identified as
Hispanic were slightly more likely to test positive for TB than household contacts that
identified as White (β=0.17, SE(β)=0.21, z=0.82, p=.41), this difference was not
significant. Household contacts that identified as Other race were more likely to test
positive for TB than household contacts that identified as White (β=0.52, SE(β)=0.30,
z=1.69, p=.09) although this difference only approached significance. Household contacts
that identified as Other race are 1.68 times (OR 95% CI: 0.93, 3.03) more likely to test
positive for TB than household contacts that identified as White.
Borough of residence was a significant predictor of whether a household contact
would test positive for TB. Household contacts that lived in Brooklyn were significantly
more likely to test positive for TB than household contacts that lived in the Bronx,
β=0.59, SE(β)=0.15, z=3.94, p<.001. Household contacts that lived in Brooklyn are 1.8
times (OR 95% CI: 1.34, 2.42) more likely to test positive for TB than household
contacts that lived in the Bronx. Household contacts that lived in Manhattan were
significantly more likely to test positive for TB than household contacts that lived in the
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Bronx, β=0.44, SE(β)=0.21, z=2.08, p<.05. Household contacts that lived in Manhattan
are 1.55 times (OR 95% CI: 1.03, 2.34) more likely to test positive for TB than household
contacts that lived in the Bronx. Household contacts that lived in Queens were
significantly more likely to test positive for TB than household contacts that lived in the
Bronx, β=0.60, SE(β)=0.14, z=4.19, p<.001. Household contacts that lived in Queens are
1.82 times (OR 95% CI: 1.38, 2.39) more likely to test positive for TB than household
contacts that lived in the Bronx. Household contacts that lived in Staten Island were
significantly more likely to test positive for TB than household contacts that lived in the
Bronx, β=0.83, SE(β)=0.36, z=2.34, p<.05. Household contacts that lived in Staten Island
are 2.3 times (OR 95% CI: 1.13, 4.64) more likely to test positive for TB than household
contacts that lived in the Bronx.

Model 5 – Gender (Full Model)
A fifth model was fit to the data which looked at the household contact gender as
a predictor of whether the household contact test positive for TB in addition to the
variables in model 4. The model was not a significantly better fit than a model which did
not include gender as a predictor variable, χ2(1)=0.99, p=.32. Gender was not a
significant predictor of whether a household contact test positive or not for TB,
controlling for age, country of birth, race/ethnicity, and borough of residence.
However, the full model which included age, country of birth, race/ethnicity,
borough of residence, and gender was a significantly better fit than the null intercept-only
model, χ2(13)=231.1, p=<0.000.
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Age group was a significant predictor of whether a household contact would test
positive for TB. Household contacts aged 18-44 are significantly more likely to test
positive for TB than household contacts younger than 18 are to test positive for TB,
β=0.31, SE(β)=0.14, z=2.23, p<.05. They are 1.36 times (OR 95% CI: 1.04, 1.79) as
likely to test positive for TB than minors. Household contacts aged 45-64 are
significantly more likely to test positive for TB than household contacts less than 18 are
to test positive for TB, β=0.54, SE(β)=0.16, z=3.37 p<.001. They are 1.72 times (OR 95%
CI: 1.25, 2.35) as likely to test positive for TB than minors. Household contacts aged 65+
are significantly more likely to test positive for TB than household contacts less than 18
are to test positive for TB, β=0.65, SE(β)=0.22, z=3.01, p<.01. They are 1.92 times (OR
95% CI: 1.24, 2.95) as likely to test positive for TB than minors.
Country of birth was a significant predictor of whether a household contact would
test positive for TB. Household contacts born outside of the US were significantly more
likely to test positive for TB than household contacts born in the US, β=1.09, SE(β)=0.13,
z=8.09, p<.001. They are 2.97 times (OR 95% CI: 2.31, 3.84) as likely to test positive for
TB than household contacts born in the US.
Race/Ethnicity was not a significant predictor of whether a household contact
would test positive for TB. Although household contacts that identified as Asian were
slightly less likely to test positive for TB than household contacts that identified as White
(β=-0.06, SE(β)=0.20, z=-0.28, p=.78), this difference was not significant. Although
household contacts that identified as Black were slightly more likely to test positive for
TB than household contacts that identified as White (β=0.04, SE(β)=0.21, z=0.18, p=.86),
this difference was not significant. Although household contacts that identified as
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Hispanic were slightly more likely to test positive for TB than household contacts that
identified as White (β=0.17, SE(β)=0.21, z=0.82, p=.41), this difference was not
significant. Household contacts that identified as Other race were more likely to test
positive for TB than household contacts that identified as White (β=0.52, SE(β)=0.31,
z=1.70, p=.09) although this difference only approached significance. Household contacts
that identified as Other race are 1.68 times (OR 95% CI: 0.93, 3.07) more likely to test
positive for TB than household contacts that identified as White.
Borough of residence was a significant predictor of whether a household contact
would test positive for TB. Household contacts that lived in Brooklyn were significantly
more likely to test positive for TB than household contacts that lived in the Bronx,
β=0.59, SE(β)=0.15, z=3.95, p<.001. Household contacts that lived in Brooklyn are 1.80
times (OR 95% CI: 1.35, 2.42) more likely to test positive for TB than household
contacts that lived in the Bronx. Household contacts that lived in Manhattan were
significantly more likely to test positive for TB than household contacts that lived in the
Bronx, β=0.44, SE(β)=0.21, z=2.09, p<.05. Household contacts that lived in Manhattan
are 1.55 times (OR 95% CI: 1.03, 2.34) more likely to test positive for TB than household
contacts that lived in the Bronx. Household contacts that lived in Queens were
significantly more likely to test positive for TB than household contacts that lived in the
Bronx, β=0.60, SE(β)=0.14, z=4.18, p<.001. Household contacts that lived in Queens are
1.82 times (OR 95% CI: 1.38, 2.42) more likely to test positive for TB than household
contacts that lived in the Bronx. Household contacts that lived in Staten Island were
significantly more likely to test positive for TB than household contacts that lived in the
Bronx, β=0.83, SE(β)=0.36, z=2.35, p<.05. Household contacts that lived in Staten Island
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are 2.30 times (OR 95% CI: 1.14, 4.62) more likely to test positive for TB than household
contacts that lived in the Bronx.
Gender was not a significant predictor of whether a household contact would test
positive for TB. Although household contacts that identified as Male were slightly less
likely to test positive for TB than household contacts that identified as Female (β=0.09,
SE(β)=0.09, z=1.00, p=.32), this difference was not significant
Therefore, age, non-US born, and borough are significant predictors; gender and
race/ethnicity are non-significant predictors of a TB test positive among contacts.

Table 27. Demographic Characteristics Associated with Positive Versus Negative TB
Test Result (Beta Coefficient and Standard Error in Parentheses)
===============================================================
Dependent Variable: TB Test Positive vs TB Test Negative
Model

(1)

(2)

(3)

(4)

(5)

Independent Variable:
-----------------------------------------------------------------------------------------------------------Age Group
0-17 (Reference)
18-44
0.984***
0.309**
0.309**
0.313** 0.312**
(0.113)
(0.139)
(0.140)
(0.140)
(0.141)
45-64

65+

1.248***
(0.131)

0.512***
(0.156)

0.522***
(0.158)

0.533*** 0.537***
(0.159)
(0.159)

1.351***
(0.193)

0.590***
(0.214)

0.617***
(0.215)

0.638*** 0.654***
(0.216)
(0.217)

1.105***
(0.129)

1.094***
(0.133)

1.094*** 1.086***
(0.134)
(0.134)

Country of Birth
US Born (Reference)
Non-US Born

Race/Ethnicity
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White (Reference)
Asian

-0.035
(0.198)

-0.063
(0.202)

-0.057
(0.202)

Black

-0.071
(0.211)

0.034
(0.214)

0.038
(0.214)

Hispanic

0.065
(0.200)

0.169
(0.205)

0.168
(0.205)

Other Race

0.499*
(0.300)

0.516*
(0.305)

0.518*
(0.305)

Borough
Bronx (Reference)
Brooklyn

0.587***
(0.149)

0.589***
(0.149)

Manhattan

0.436**
(0.210)

0.438**
(0.210)

Queens

0.600***
(0.143)

0.599***
(0.143)

Staten Is.

0.831**
(0.355)

0.834**
(0.355)

Gender
Female (Reference)
Male

Constant

-1.166***
(0.094)

0.091
(0.091)
-1.427***
(0.102)

-1.435***
(0.203)

-1.980*** -2.024***
(0.242)
(0.246)

-----------------------------------------------------------------------------------------------------------Observations
2,257
2,257
2,257
2,257
2,257
Log Likelihood
-1,468.496
-1,429.399 -1,426.521 -1,416.034 -1,415.537
Akaike Inf. Crit.
2,944.992
2,868.799 2,871.042 2,858.068 2,859.074
===============================================================
Note:
*p<0.1; **p<0.05; ***p<0.01

Fully Evaluated
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The factors impacting likelihood of a household contact being fully evaluated are
explored. Logistic regression models were fit to the data to see if age group, country of
birth, race/ethnicity, and borough of residence impacted likelihood of a household contact
being fully evaluated and to explore how these variables interact.
Four demographic variables were found to be significant predictors of fully
evaluated contacts, after controlling for all other variables in the model: gender, agegroup, non-US born, and race/ethnicity. As illustrated in Table 28, the only demographic
characteristic that was found to be significant predictors of being fully evaluated after
controlling for all other variables: gender, age-group, non-US born, and race/ethnicity.
The following explains the stepwise logistic regression models.

Model 1 – Country of Birth
A model was fit to the data which looked at the household contact country of birth
as a predictor of whether the household was fully evaluated. The model was a
significantly better fit than a model which did not include country of birth as a predictor
variable, χ2(1)=19.23, p<.001.
Country of birth was a significant predictor of whether a household contact was
fully evaluated. Household contacts born outside of the US were significantly less likely
to be fully evaluated than household contacts born in the US, β=-0.65, SE(β)=0.16, z=4.18, p<.001. Household contacts born outside of the US are 0.52 times (OR 95% CI:
0.38, 0.71) as likely to be fully evaluated than household contacts born in the US.

Model 2 – Gender
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A second model was fit to the data which looked at the household contact gender
as a predictor of whether the household contact was fully evaluated in addition to the
variables in model 1. The model was a significantly better fit than a model which did not
include gender as a predictor variable, χ2(1)=7.77, p<.01.
Country of birth was a significant predictor of whether a household contact was
fully evaluated. Household contacts born outside of the US were significantly less likely
to be fully evaluated than household contacts born in the US, β=-0.64, SE(β)=0.16, z=4.05, p<.001. Household contacts born outside of the US are 0.53 times (OR 95% CI:
0.39, 0.72) as likely to be fully evaluated than household contacts born in the US.
Gender was a significant predictor of whether a household contact was fully
evaluated. Household contacts that identified as Male were significantly less likely to be
fully evaluated than household contacts that identified as Female, β=-0.37, SE(β)=0.13,
z=-2.78, p<.01. Household contacts identified as Male are 0.69 times (OR 95% CI: 0.54,
0.89) as likely to be fully evaluated than household contacts identified as Female.

Model 3 – Age
A third model was fit to the data which looked at the household contact age as a
predictor of whether the household contact was fully evaluated in addition to the
variables in model 2. The model was a significantly better fit than a model which did not
include age as a predictor variable, χ2(3)=73.51, p<.001.
Country of birth was not a significant predictor of whether a household contact
was fully evaluated. Although household contacts born outside of the US were slightly
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more likely to be fully evaluated than household contacts born in the US (β=0.28,
SE(β)=0.18, z=1.57, p=.12), this difference was not significant.
Gender was a significant predictor of whether a household contact was fully
evaluated. Household contacts that identified as Male were significantly less likely to be
fully evaluated than household contacts that identified as Female, β=-0.38, SE(β)=0.13,
z=-2.84, p<.01. Household contacts identified as Male are 0.68 times (OR 95% CI: 0.53,
0.88) as likely to be fully evaluated than household contacts identified as Female.
Age group was a significant predictor of whether a household contact was fully
evaluated. Household contacts aged 18-44 are significantly less likely to be fully
evaluated than household contacts younger than 18 are to be fully evaluated, β=-2.09,
SE(β)=0.29, z=-7.31, p<.001. They are 0.12 times (OR 95% CI: 0.07, 0.22) less likely to
be fully evaluated than minors. Household contacts aged 45-64 are significantly less
likely to be fully evaluated than household contacts younger than 18 are to be fully
evaluated, β=-2.07, SE(β)=0.31, z=-6.77, p<.001. They are 0.13 times (OR 95% CI: 0.07,
0.23) less likely to be fully evaluated than minors. Household contacts aged 65+ are
significantly less likely to be fully evaluated than household contacts younger than 18 are
to be fully evaluated, β=-1.86, SE(β)=0.38, z=-4.84, p<.001. They are 0.16 times (OR
95% CI: 0.07, 0.33) less likely to be fully evaluated than minors.
Therefore, age is associated with not being fully evaluated. The older the person,
the less likely for a household contact to be fully evaluated.

Model 4 – Borough
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A fourth model was fit to the data which looked at the household contact borough
of residence as a predictor of whether the household contact was fully evaluated in
addition to the variables in model 3. The model was not a significantly better fit than a
model which did not include borough of residence as a predictor variable, χ2(4)=3.16,
p=.53. Borough of residence was not a significant predictor of whether a household
contact was fully evaluated, controlling for country of birth, gender, and age.

Model 5 – Race/Ethnicity (Full Model)
A fifth model was fit to the data which looked at the household contact
race/ethnicity as a predictor of whether the household contact was fully evaluated in
addition to the variables in model 4. The model was not a significantly better fit than a
model which did not include race/ethnicity as a predictor variable, χ2(4)=11.41, p<.05.
Additionally, the full model was a significantly better fit than the null intercept-only
model, χ2(13)=115.1, p=< 0.00001.
Country of birth was not a significant predictor of whether a household contact
was fully evaluated. Although household contacts born outside of the US were slightly
more likely to be fully evaluated than household contacts born in the US (β=0.12,
SE(β)=0.19, z=0.65, p=.52), this difference was not significant.
Gender was a significant predictor of whether a household contact was fully
evaluated. Household contacts that identified as Male were significantly less likely to be
fully evaluated than household contacts that identified as Female, β=-0.38, SE(β)=0.14,
z=-2.78, p<.01. Household contacts identified as Male are 0.69 times (OR 95% CI: 0.52,
0.89) less likely to be fully evaluated than household contacts identified as Female.
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Age group was a significant predictor of whether a household contact was fully
evaluated. Household contacts aged 18-44 are significantly less likely to be fully
evaluated than household contacts younger than 18 are to be fully evaluated, β=-2.01,
SE(β)=0.29, z=-7.02, p<.001. They are 0.13 times (OR 95% CI: 0.07, 0.23) less likely to
be fully evaluated than minors. Household contacts aged 45-64 are significantly less
likely to be fully evaluated than household contacts younger than 18 are to be fully
evaluated, β=-1.98, SE(β)=0.31, z=-6.43, p<.001. They are 0.14 times (OR 95% CI: 0.07,
0.25) less likely to be fully evaluated than minors. Household contacts aged 65+ are
significantly less likely to be fully evaluated than household contacts younger than 18 are
to be fully evaluated, β=-1.76, SE(β)=0.39, z=-4.57, p<.001. They are 0.17 times (OR
95% CI: 0.08, 0.37) less likely to be fully evaluated than minors.
Borough of residence was not a significant predictor of whether a household
contact was fully evaluated. Although household contacts that lived in Brooklyn were
slightly less likely to be fully evaluated than household contacts that lived in the Bronx
(β=-0.18, SE(β)=0.22, z=-0.85, p=.40), this difference was not significant. Although
household contacts that lived in Manhattan were slightly less likely to be fully evaluated
than household contacts that lived in the Bronx (β=-0.25, SE(β)=0.30, z=-0.83, p=.41),
this difference was not significant. Although household contacts that lived in Queens
were slightly less likely to be fully evaluated than household contacts that lived in the
Bronx (β=-0.30, SE(β)=0.21, z=-1.44, p=.15), this difference was not significant.
Although household contacts that lived in Staten Island were slightly more likely to be
fully evaluated than household contacts that lived in the Bronx (β=0.77, SE(β)=0.76,
z=1.01, p=.31), this difference was not significant.
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Race/Ethnicity was a significant predictor of whether a household contact was
fully evaluated. Household contacts that identified as Asian were significantly more
likely to be fully evaluated than household contacts that identified as White, β=0.60,
SE(β)=0.27, z=2.21, p<.05. Household contacts identified as Asian are 1.81 times (OR
95% CI: 1.05, 3.04) more likely to be fully evaluated than household contacts identified
as White. Although household contacts that identified as Black were slightly more likely
to be fully evaluated than household contacts that identified as White (β=0.004,
SE(β)=0.28, z=0.02, p=.99), this difference was not significant. Although household
contacts that identified as Hispanic were slightly more likely to be fully evaluated than
household contacts that identified as White (β=0.48, SE(β)=0.27, z=1.74, p=.08), this
difference only approached significance. Household contacts identified as Hispanic are
1.61 times (OR 95% CI: 0.93, 2.73) more likely to be fully evaluated than household
contacts identified as White. Although household contacts that identified as Other race
were slightly more likely to be fully evaluated than household contacts that identified as
White (β=0.38, SE(β)=0.92, z=0.36, p=.60), this difference was not significant.
Therefore, non-US born, male gender, and older household contacts are less likely
to be fully evaluated. However, Asian as race/ethnicity of contacts are more likely fully
evaluated.
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Table 28. Demographic Characteristics Associated with Full Evaluation (Beta
Coefficient and Standard Error in Parentheses)
===============================================================
Dependent Variable: Fully Evaluated
Model

(1)

(2)

(3)

(4)

(5)

Independent Variable:
-----------------------------------------------------------------------------------------------------------Country of Birth:
US Born (Reference)
Non-US Born
-0.655***
-0.635***
0.284
0.298
0.124
(0.157)
(0.157)
(0.181)
(0.185)
(0.191)
Gender:
Female (Reference)
Male

Age Group:
0-17 (Reference)
18-44

-0.366***
(0.132)

-0.382*** -0.383*** -0.377***
(0.135)
(0.135)
(0.136)

-2.091***
(0.286)

-2.096*** -2.013***
(0.287)
(0.287)

45-64

-2.073***
(0.306)

-2.076***
(0.307)

-1.980***
(0.308)

65+

-1.857*** -1.847***
(0.383)
(0.385)

-1.760***
(0.386)

Borough:
Bronx (Reference)
Brooklyn

-0.186
(0.211)

-0.184
(0.217)

Manhattan

-0.199
(0.301)

-0.253
(0.305)

Queens

-0.166
(0.202)

-0.304
(0.211)

Staten Is.

0.808

0.765
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(0.752)
Race/Ethnicity:
White (Reference)
Asian

(0.758)

0.595**
(0.270)

Black

0.004
(0.275)

Hispanic

0.477*
(0.275)

Other

0.381
(0.414)

Constant

2.476***
(0.138)

2.657***
(0.155)

3.729***
(0.258)

3.860***
(0.303)

3.594***
(0.389)

-----------------------------------------------------------------------------------------------------------Observations
2,257
2,257
2,257
2,257
2,257
Log Likelihood
-814.860
-810.972
-774.220
-772.638
-766.934
Akaike Inf. Crit.
1,633.720
1,627.945 1,560.440 1,565.277
1,561.867
===============================================================
Note:
*p<0.1; **p<0.05; ***p<0.01

Accepted LTBI treatment
The factors impacting likelihood of a household contact accepting LTBI treatment
are explored. Logistic regression models were fit to the data to see if age group, country
of birth, race/ethnicity, and borough of residence impacted likelihood of a household
contact accepting LTBI treatment and to explore how these variables interact.
Three demographic variables were found to be significant predictors of accepting
LTBI treatment, after controlling for all other variables in the model: age-group, non-US
born, and race/ethnicity. As illustrated in Table 29, the only demographic characteristic
that was found to be significant predictors of accepting LTBI treatment after controlling
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for all other variables are age, non-US born, race/ethnicity. The following explains the
stepwise logistic regression models.

Model 1 – Age
A model was fit to the data which looked at the household contact age as a
predictor of whether the household accepted LTBI treatment. The model was not a
significantly better fit than a model which did not include age as a predictor variable,

χ2(3)=5.38, p=.15. Age was not a significant predictor of whether a household contact
accepted LTBI treatment

Model 2 – Country of Birth
A second model was fit to the data which looked at the household contact country
of birth as a predictor of whether the household contact accepted LTBI treatment in
addition to the variables in model 1. The model was a significantly better fit than a model
which did not include country of birth as a predictor variable, χ2(1)=32.39, p<.001.
Age group was not a significant predictor of whether a household contact would
accept LTBI treatment. However, household contacts aged 18-44 are significantly less
likely to accept LTBI treatment than household contacts younger than 18 are to accept
LTBI treatment, β=-0.41, SE(β)=0.16, z=-2.56, p<.05. They are 0.66 times (OR 95% CI:
0.49, 0.91) less likely to accept LTBI treatment than minors. Although household
contacts aged 45-64 are slightly less likely to accept LTBI treatment than household
contacts less than 18 are to accept LTBI treatment (β=-0.25, SE(β)=0.18, z=-1.40, p=.16),
this difference was not significant. Although household contacts aged 65+ are slightly
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less likely to accept LTBI treatment than household contacts less than 18 are to accept
LTBI treatment (β=-0.39, SE(β)=0.25, z=-1.59, p=.11), this difference was not
significant.
Country of birth was a significant predictor of whether a household contact would
accept LTBI treatment. Household contacts born outside of the US were significantly
more likely to accept LTBI treatment than household contacts born in the US, β=0.85,
SE(β)=0.15, z=5.50, p<.001. Household contacts born outside of the US are 2.34 times
(OR 95% CI: 1.74, 3.14) more likely to accept LTBI treatment than household contacts
born in the US.

Model 3 – Borough of Residence
A third model was fit to the data which looked at the household contact borough
of residence as a predictor of whether the household contact accepted LTBI treatment in
addition to the variables in model 2. The model was not a significantly better fit than a
model which did not include borough of residence as a predictor variable, χ2(4)=3.91,
p=.42. Borough of residence was not a significant predictor of whether a household
contact accepted LTBI treatment, controlling for age, and country of birth.

Model 4 – Race (Full Model)
A fourth model was fit to the data which looked at the household contact
race/ethnicity as a predictor of whether the household contact accepted LTBI treatment in
addition to the variables in model 3. The model was a significantly better fit than a model
which did not include race/ethnicity as a predictor variable, χ2(4)=11.21, p<.05.
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Additional, the full model which included age, country of birth, borough of residence,
and race/ethnicity was a significantly better fit than the null intercept-only model,

χ2(12)=52.9, p=<0.00001.
Age group was not a significant predictor of whether a household contact would
accept LTBI treatment. Household contacts aged 18-44 are significantly less likely to
accept LTBI treatment than household contacts younger than 18 are to accept LTBI
treatment, β=-0.38, SE(β)=0.16, z=-2.32, p<.05. They are 0.68 times (OR 95% CI: 0.50,
0.94) as likely to accept LTBI treatment than minors. Although household contacts aged
45-64 are slightly less likely to accept LTBI treatment than household contacts less than
18 are to accept LTBI treatment (β=-0.20, SE(β)=0.18, z=-1.13, p=.26), this difference
was not significant. Although household contacts aged 65+ are slightly less likely to
accept LTBI treatment than household contacts less than 18 are to accept LTBI treatment
(β=-0.33, SE(β)=0.25, z=-1.34, p=.18), this difference was not significant.
Country of birth was a significant predictor of whether a household contact would
accept LTBI treatment. Household contacts born outside of the US were significantly
more likely to accept LTBI treatment than household contacts born in the US, β=0.76,
SE(β)=0.16, z=4.75, p<.001. Household contacts born outside of the US are 2.14 times
(OR 95% CI: 1.56, 2.93) more likely to accept LTBI treatment than household contacts
born in the US.
Borough of residence was not a significant predictor of whether a household
contact would accept LTBI treatment. Although household contacts that lived in
Brooklyn were slightly more likely to accept LTBI treatment than household contacts that
lived in the Bronx (β=0.32, SE(β)=0.17, z=1.91, p=.06), this difference only approached
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significance. Household contacts that lived in Brooklyn are 1.38 times (OR 95% CI: 0.99,
1.92) more likely to accept LTBI treatment than household contacts that lived in the
Bronx. Although household contacts that lived in Manhattan were slightly more likely to
accept LTBI treatment than household contacts that lived in the Bronx (β=0.08,
SE(β)=0.25, z=0.34, p=.73), this difference was not significant. Although household
contacts that lived in Queens were slightly more likely to accept LTBI treatment than
household contacts that lived in the Bronx (β=0.19, SE(β)=0.16, z=1.14, p=.25), this
difference was not significant. Although household contacts that lived in Staten Island
were slightly more likely to accept LTBI treatment than household contacts that lived in
the Bronx (β=0.39, SE(β)=0.40, z=0.97, p=.33), this difference was not significant.
Race/Ethnicity was a significant predictor of whether a household contact would
accept LTBI treatment. Household contacts that identified as Asian were significantly
more likely to accept LTBI treatment than household contacts that identified as White,
β=0.52, SE(β)=0.26, z=2.02, p<.05. Household contacts identified as Asian are 1.68
times (OR 95% CI: 1.01, 2.80) more likely to accept LTBI treatment than household
contacts identified as White. Although household contacts that identified as Black were
slightly more likely to accept LTBI treatment than household contacts that identified as
White (β=0.15, SE(β)=0.28, z=0.55, p=.58), this difference was not significant.
Household contacts that identified as Hispanic were significantly more likely to accept
LTBI treatment than household contacts that identified as White, β=0.57, SE(β)=0.26,
z=2.19, p<.05. Household contacts identified as Hispanic are 1.77 times (OR 95% CI:
1.06, 2.94) more likely to accept LTBI treatment than household contacts identified as
White. Although household contacts that identified as Other race were slightly more
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likely to accept LTBI treatment than household contacts that identified as White (β=0.65,
SE(β)=0.36, z=1.84, p=.07), this difference only approached significance. Household
contacts identified as Other race are 1.92 times (OR 95% CI: 0.95, 3.88) more likely to
accept LTBI treatment than household contacts identified as White.
Therefore, among the race/ethnicity, Asian and Hispanic are significant predictors
of accepting LTBI treatment.

Table 29. Demographic Characteristics Associated with Accepted LTBI Treatment
(Beta Coefficient and Standard Error in Parentheses)
===============================================================
Dependent variable: Accepted LTBI Treatment
Model

(1)

(2)

(3)

(4)

Independent Variable:
-----------------------------------------------------------------------------------------------------------Age Group
0-17 (Reference)
18-44
0.127
-0.408**
-0.406**
-0.375**
(0.126)
(0.159)
(0.159)
(0.162)
45-64

0.330**
(0.144)

-0.249
(0.178)

-0.251
(0.178)

-0.205
(0.181)

65+

0.205
(0.223)

-0.393
(0.247)

-0.384
(0.248)

-0.335
(0.251)

0.849***
(0.154)

0.837***
(0.156)

0.761***
(0.160)

0.287*
(0.164)

0.326*
(0.171)

0.102

0.085

Country of Birth
US Born (reference)
Non-US Born

Borough
Bronx (Reference)
Brooklyn

Manhattan

85
(0.243)

(0.246)

Queens

0.256
(0.157)

0.187
(0.164)

Staten Is.

0.346
(0.392)

0.385
(0.398)

Race/Ethnicity
White (Reference)
Asian

0.517**
(0.256)

Black

0.151
(0.275)

Hispanic

0.569**
(0.260)

Other

0.654*
(0.357)

Constant

-1.390***
(0.100)

-1.589***
(0.110)

-1.800***
(0.165)

-2.205***
(0.296)

----------------------------------------------------------------------------------------------------------Observations
2,257
2,257
2,257
2,257
Log Likelihood
-1,195.909 -1,179.712
-1,177.755
-1,172.152
Akaike Inf. Crit.
2,399.818
2,369.425
2,373.511
2,370.303
===============================================================
Note:
*p<0.1; **p<0.05; ***p<0.01

Refused LTBI treatment
The factors impacting likelihood of a household contact refusing LTBI treatment
are explored. Logistic regression models were fit to the data to see if age group, country
of birth, race/ethnicity, and borough of residence impacted likelihood of a household
contact refusing LTBI treatment and to explore how these variables interact.
Two demographic variables were found to be significant predictors of refusing
LTBI treatment, after controlling for all other variables in the model: age-group and
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borough. As illustrated in Table 30, the only demographic characteristic that was found to
be significant predictors of refused LTBI treatment after controlling for all other variables
is age-group and borough. The following explains the stepwise logistic regression
models.

Model 1 – Age
A model was fit to the data which looked at the household contact age as a
predictor of whether the household refused LTBI treatment. The model was a
significantly better fit than a model which did not include age as a predictor variable,

χ2(3)=155.88, p<.001.
Age group was a significant predictor of whether a household contact would
refuse LTBI treatment. Household contacts aged 18-44 are significantly more likely to
refuse LTBI treatment than household contacts younger than 18 are to refuse LTBI
treatment, β=2.51, SE(β)=0.32, z=7.97, p<.001. They are 12.3 times (OR 95% CI: 6.57,
23.04) as likely to refuse LTBI treatment than minors. Household contacts aged 45-64 are
significantly more likely to refuse LTBI treatment than household contacts less than 18
are to refuse LTBI treatment, β=2.75, SE(β)=0.32, z=8.50, p<.001. They are 15.64 times
(OR 95% CI: 8.35, 29.29) as likely to refuse LTBI treatment than minors. Household
contacts aged 65+ are significantly more likely to refuse LTBI treatment than household
contacts less than 18 are to refuse LTBI treatment, β=2.63, SE(β)=0.37, z=7.10, p<.001.
They are 13.47 times (OR 95% CI: 6.72, 28.65) as likely to refuse LTBI treatment than
minors.
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Therefore, age is a significant predictor of refused LTBI treatment. Household
contacts ages 45-64 are more likely to refuse LTBI treatment.

Model 2 – Country of Birth
A second model was fit to the data which looked at the household contact country
of birth as a predictor of whether the household contact refused LTBI treatment in
addition to the variables in model 1. The model was not a significantly better fit than a
model which did not include country of birth as a predictor variable, χ2(1)=0.01, p=.94.
Country of birth was not a significant predictor of whether a household contact refused
LTBI treatment, controlling for age.

Model 3 – Borough of Residence
A third model was fit to the data which looked at the household contact borough
of residence as a predictor of whether the household contact refused LTBI treatment in
addition to the variables in model 2. The model was a significantly better fit than a model
which did not include borough of residence as a predictor variable, χ2(3)=14.30, p<.01.
Age group was a significant predictor of whether a household contact would
refuse LTBI treatment. Household contacts aged 18-44 are significantly more likely to
refuse LTBI treatment than household contacts younger than 18 are to refuse LTBI
treatment, β=2.52, SE(β)=0.34, z=7.51, p<.001. They are 12.43 times (OR 95% CI: 6.38,
24.2) as likely to refuse LTBI treatment than minors. Household contacts aged 45-64 are
significantly more likely to refuse LTBI treatment than household contacts less than 18
are to refuse LTBI treatment, β=2.75, SE(β)=0.35, z=7.89, p<.001. They are 15.64 times
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(OR 95% CI: 7.88, 31.06) as likely to refuse LTBI treatment than minors. Household
contacts aged 65+ are significantly more likely to refuse LTBI treatment than household
contacts less than 18 are to refuse LTBI treatment, β=2.64, SE(β)=0.39, z=6.70, p<.001.
They are 14.01 times (OR 95% CI: 6.52, 30.1) as likely to refuse LTBI treatment than
minors.
Country of birth was not a significant predictor of whether a household contact
would refuse LTBI treatment. Although household contacts born outside of the US were
slightly less likely to refuse LTBI treatment than household contacts born in the US (β=0.01, SE(β)=0.18, z=-0.03, p=.98), this difference was not significant.
Borough of residence was a significant predictor of whether a household contact
would refuse LTBI treatment. Household contacts that lived in Brooklyn were
significantly more likely to refuse LTBI treatment than household contacts that lived in
the Bronx, β=0.72, SE(β)=0.22, z=3.29, p<.001. Household contacts that lived in
Brooklyn are 2.05 times (OR 95% CI: 1.33, 3.16) more likely to refuse LTBI treatment
than household contacts that lived in the Bronx. Although household contacts that lived
in Manhattan were slightly more likely to refuse LTBI treatment than household contacts
that lived in the Bronx (β=0.51, SE(β)=0.30, z=1.70, p=.09), this difference only
approached significance. Household contacts that lived in Manhattan are 1.67 times (OR
95% CI: 0.92, 3.00) more likely to refuse LTBI treatment than household contacts that
lived in the Bronx. Household contacts that lived in Queens were significantly more
likely to refuse LTBI treatment than household contacts that lived in the Bronx, β=0.58,
SE(β)=0.21, z=2.73, p<.01. Household contacts that lived in Queens are 1.79 times (OR
95% CI: 1.18, 2.70) more likely to refuse LTBI treatment than household contacts that
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lived in the Bronx. Household contacts that lived in Staten Island were significantly more
likely to refuse LTBI treatment than household contacts that lived in the Bronx, β=1.17,
SE(β)=0.44, z=2.64, p<.01. Household contacts that lived in Staten Island are 3.22 times
(OR 95% CI: 1.36, 7.63) more likely to refuse LTBI treatment than household contacts
that lived in the Bronx.

Model 4 – Race (Full Model)
A fourth model was fit to the data which looked at the household contact
race/ethnicity as a predictor of whether the household contact refused LTBI treatment in
addition to the variables in model 3. The model was not significantly better fit than a
model which did not include race/ethnicity as a predictor variable, χ2(4)=13.65, p<.01.
Race/ethnicity was not a significant predictor of whether a household contact refused
LTBI treatment, controlling for age, country of birth, borough of residence. However, the
full model which included age, country of birth, borough of residence, and race/ethnicity
was a significantly better fit than the null intercept-only model χ2(12)=183.8,
p=<0.00001.
Age group was a significant predictor of whether a household contact would
refuse LTBI treatment. Household contacts aged 18-44 are significantly more likely to
refuse LTBI treatment than household contacts younger than 18 are to refuse LTBI
treatment, β=2.45, SE(β)=0.34, z=7.31, p<.001. They are 11.59 times (OR 95% CI: 5.95,
22.56) as likely to refuse LTBI treatment than minors. Household contacts aged 45-64 are
significantly more likely to refuse LTBI treatment than household contacts less than 18
are to refuse LTBI treatment, β=2.65, SE(β)=0.35, z=7.61, p<.001. They are 14.15 times
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(OR 95% CI: 7.13, 28.12) as likely to refuse LTBI treatment than minors. Household
contacts aged 65+ are significantly more likely to refuse LTBI treatment than household
contacts less than 18 are to refuse LTBI treatment, β=2.54, SE(β)=0.39, z=6.45, p<.001.
They are 12.68 times (OR 95% CI: 5.90, 27.23) as likely to refuse LTBI treatment than
minors.
Country of birth was not a significant predictor of whether a household contact
would refuse LTBI treatment. Although household contacts born outside of the US were
slightly more likely to refuse LTBI treatment than household contacts born in the US
(β=0.14, SE(β)=0.19, z=0.72, p=.47), this difference was not significant.
Borough of residence was a significant predictor of whether a household contact
would refuse LTBI treatment. Household contacts that lived in Brooklyn were
significantly more likely to refuse LTBI treatment than household contacts that lived in
the Bronx, β=0.70, SE(β)=0.22, z=3.11, p<.01. Household contacts that lived in Brooklyn
are 2.01 times (OR 95% CI: 1.31, 6.24) more likely to refuse LTBI treatment than
household contacts that lived in the Bronx. Although household contacts that lived in
Manhattan were slightly more likely to refuse LTBI treatment than household contacts
that lived in the Bronx (β=0.57, SE(β)=0.30, z=1.88, p=.06), this difference only
approached significance. Household contacts that lived in Manhattan are 1.77 times (OR
95% CI: 0.98, 3.18) more likely to refuse LTBI treatment than household contacts that
lived in the Bronx. Household contacts that lived in Queens were significantly more
likely to refuse LTBI treatment than household contacts that lived in the Bronx, β=0.65,
SE(β)=0.22, z=2.93, p<.01. Household contacts that lived in Queens are 1.92 times (OR
95% CI: 1.24, 2.95) more likely to refuse LTBI treatment than household contacts that
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lived in the Bronx. Household contacts that lived in Staten Island were significantly more
likely to refuse LTBI treatment than household contacts that lived in the Bronx, β=1.24,
SE(β)=0.45, z=2.78, p<.01. Household contacts that lived in Staten Island are 3.46 times
(OR 95% CI: 1.43, 8.35) more likely to refuse LTBI treatment than household contacts
that lived in the Bronx.
Race/Ethnicity was not a significant predictor of whether a household contact
would refuse LTBI treatment. Although household contacts that identified as Asian were
slightly less likely to refuse LTBI treatment than household contacts that identified as
White (β=-0.08, SE(β)=0.27, z=-0.31, p=.76), this difference was not significant.
Although household contacts that identified as Black were slightly more likely to refuse
LTBI treatment than household contacts that identified as White (β=0.43, SE(β)=0.28,
z=1.52, p=.13), this difference was not significant. Although household contacts that
identified as Hispanic were slightly less likely to refuse LTBI treatment than household
contacts that identified as White (β=-0.17, SE(β)=0.28, z=-0.61, p=.55), this difference
was not significant. Although household contacts that identified as Other race were
slightly more likely to refuse LTBI treatment than household contacts that identified as
White (β=0.48, SE(β)=0.38, z=1.27, p=.20), this difference was not significant.
Therefore, household contacts residing from Brooklyn, Queens, and Staten Island
are more likely to refuse LTBI treatment.
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Table 30. Demographic Characteristics Associated with Refused LTBI Treatment
(Beta Coefficient and Standard Error in Parentheses)
===============================================================
Dependent variable: Refused LTBI Treatment
Model

(1)

(2)

(3)

(4)

Independent Variable:
-----------------------------------------------------------------------------------------------------------Age Group
0-17 (Reference)
18-44
2.512***
2.503***
2.521***
2.451***
(0.315)
(0.335)
(0.335)
(0.335)
45-64

2.749***
(0.323)

2.739***
(0.347)

2.747***
(0.348)

2.651***
(0.348)

65+

2.630***
(0.370)

2.620***
(0.392)

2.638***
(0.394)

2.544***
(0.395)

Country of Birth:
US Born (Reference)
Non-US Born

-0.005
(0.182)

0.136
(0.190)

0.720***
(0.219)

0.699***
(0.225)

Manhattan

0.512*
(0.301)

0.573*
(0.305)

Queens

0.582***
(0.213)

0.650***
(0.222)

Staten Is.

1.166***
(0.441)

1.245***
(0.449)

Borough:
Bronx (Reference)
Brooklyn

Race/Ethnicity:
White (Reference)
Asian

0.014
(0.178)

-0.083

93
(0.271)
Black

0.427
(0.281)

Hispanic

-0.171
(0.282)

Other

0.480
(0.378)

Constant

-4.025***
(0.304)

-4.028***
(0.306)

-4.584***
(0.355)

-4.680***
(0.436)

---------------------------------------------------------------------------------------------------------Observations
2,257
2,257
2,257
2,257
Log Likelihood
-854.067
-854.064
-846.912
-840.089
Akaike Inf. Crit.
1,716.135
1,718.128
1,711.825
1,706.177
===============================================================
Note:
*p<0.1; **p<0.05; ***p<0.01

Summary
The significant variables by time point in the univariate and multivariate analyses
are presented in Appendix Table A14. The VIF score in this sample were all below 2,
therefore, there was no problem with collinearity. For the bivariate analysis, the data at
different time points appeared to differ across a number of variables. The multivariate
analysis revealed a more limited set of variables predicted household contact behavior at
different time points. Age is a significant predictor behavior at three time points, TB
testing, evaluation, and LTBI treatment. On household contacts tested for TB, adults are
significantly less likely tested than minors. The older the person, the less likely they are
tested. Race/ethnicity & borough did not affect the age of the contacts tested for TB. On
household contacts fully evaluated, older household contacts, male gender, non-US born
are less likely to be fully evaluated. However, Asian and Hispanic as race/ethnicity of
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household contacts are more likely fully evaluated. Household contacts who are non-US
born that reside in Brooklyn, Queens, and Staten Island are more likely to have a TB test
positive. Moreover, older household contacts are more likely to have a TB test positive.
On accepting LTBI treatment, age of household contact alone is not a significant
predictor. However, older household contacts who are non US born are less likely to
accept LTBI treatment. Asian and Hispanic as race/ethnicity of household contacts are
more likely to accept LTBI treatment. On refusing LTBI treatment, the older the
household contacts from Brooklyn, Queens and Staten Island are more likely to refuse
LTBI treatment. And, the proportion of contacts tested, evaluated, and accepted/
completed or refused LTBI treatment did not significantly differ based on type of
provider.
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Chapter 5: Discussion
Most research has focused on active case finding and treatment of TB disease
while there are few studies examining factors associated with TB testing and evaluation
among TB contacts. This study addresses this gap by considering the demographic
factors among household contacts of active TB cases associated with TB testing as well
as evaluation and LTBI treatment.
Convincing asymptomatic household contacts to accept TB testing and evaluation
is a significant challenge for public health agencies (Zenner et al., 2017). Gaps in
knowledge about TB among contacts, and gaps in providers’ knowledge of identifying
and selecting contacts for testing are barriers to testing and evaluation of contacts
(Anderson et al., 2014; Anger et al., 2012; Cates et al., 2015; Chakhaia et al., 2014;
Dresser et al., 2012; Flood & Barry, 2017; Fox et al., 2015; Kambali et al., 2015;
Ratovoson et al., 2014). The health promotion model (HPM) of Nola Pender guided the
examination of factors that influence acceptance of TB testing and evaluation and the
selection of variables for testing, evaluation and LTBI treatment. According to HPM
understanding the factors of the major determinants of health behavior informed the
counseling of healthy behavior, which was acceptance of TB testing and evaluation. In
addition, the HMP implied that an individual was partially shaped by environment which
in this case include the social determinants of TB, cultural beliefs, and stigma that posed
as barriers that prevented contacts from getting tested and evaluated
The data from this study revealed several interesting patterns in the demographic
characteristics of those that accepted versus those that refused testing and evaluation.
Testing and evaluation are not effective if not linked to treatment of LTBI. Knowing the
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factors associated with accepting or refusing LTBI treatment is vital in planning
strategies to control TB.
TB Cases in US and New York City
In the United States (US), from 1993 to 2016, there has been an annual decline in
the number of cases and incidence of TB. Since 2010, the total number of cases in the
US has declined from 3.9 cases per 100,000 population to 2.9 cases per 100,000
population in 2016. Although, TB cases and rates have declined, non-US born and
racial/ethnic minorities were disproportionately affected by TB in the U.S. (Stennis et al.,
2015), yet the rates are also declining. In 2010, the rate of TB among the non-US born
was 18.1 cases per 100,000 population compared to 14.6 cases per 100,000 in 2016
(CDC, 2010; CDC 2016). This decline in cases among the non-US born has been
attributed to changes in the size of the non-US born entrants to the US, changes in the
distribution of country of origin among the non-US born and changes in the rate of TB
among non-US born subpopulations (Baker et al., 2016). Among the 50 states in the US,
four states (California, Texas, New York, and Florida) accounted for most TB cases. The
top five countries of origin for non-US born were Mexico, Philippines, India, Vietnam
and China (CDC, 2016). Asians continue to be the racial/ethnic group with the largest
number of TB cases (CDC2010; CDC 2016).
In New York City (N.Y.C.), from 1992 to 2016, there has been an 85% decrease
in the number of TB cases. The top five countries with high rates of TB were China,
U.S., Mexico, Philippines, and Bangladesh (BTBC, 2016). It is interesting to note that
the U.S. was among the top five countries with high rate of TB. This can be attributed to
high levels of population mobility among the non-US born that exposes the US born to
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TB (Hargreaves et al., 2011); and a greater proportion of homelessness among the US
born, together with other factors associated with homelessness such as HIV and
substance abuse which are risk factors for TB (Bamrah et al., 2013). In 2017, there were
613 confirmed cases of TB disease reported to the Department of Health and Mental
Hygiene (DOHMH) which corresponds to 7.5 per 100,000 population citywide, however,
this is more than two times the national rate (2.8 per 100,000). And a ten percent
increase in the number of TB cases from 2016 to 2017 (BTBC, 2017). Tuberculosis has
affected all age groups, and races, and yet disproportionately affects the non-US born.
Eighty six percent of all TB cases occurred among the non-US born (BTBC, 2017). The
TB rates among Asians are five times higher than US-born non-Hispanic Whites. In
2017, the highest rates of TB are seen among patients 65 years of age and older which
represents a 25% increase in the number of TB cases in these age groups (BTBC, 2017).
The proportion of TB cases among 18-44 years of age was 41%, with 63% among males
(BTBC, 2017). In addition, some neighborhoods in Queens and Brooklyn have TB rates
higher than the citywide rate, which reflects the number of TB cases residing in those
neighborhoods (BTBC, 2010; BTBC, 2016; BTBC, 2017).
In 2016, there were 3,595 contacts (household and non-household) identified in
N.Y.C. Of these contacts, 2716 had been evaluated for TB, and 1,195 were started on
treatment for LTBI (BTBC, 2016).
For this study, between the period of September 2010 and December 2014, there
were 2,751 confirmed cases of active TB reported to DOHMH. The annual rate during
this period decreased from 3.6 per 100,000 (2010) to 3.0 per 100,000 (2014). The
DOHMH identified about 6,396 household contacts during this period, however, only
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3,008 household contacts were included in data analysis. Of the 3,008 household
contacts, 2,850 were tested for TB, 1,090 were positive on TB test as evidenced of LTBI,
and 657 accepted and completed treatment. The rates from this sample differ by
demographic factors (gender, age-group, race/ethnicity, non-US born, and residence
borough) for acceptance by household contacts of TB testing, evaluation, and LTBI
treatment.
Acceptance of TB testing
Fox and colleagues (2015) identified barriers to adherence with contact
investigation including the knowledge, attitudes and practices of contacts. Gaps in
knowledge about how TB is transmitted and why testing is important influences the
likelihood to accepting testing (Anger et al., 2012; Chakhaia et al., 2014; Faccini et al.,
2015; Fox et al., 2015; Fox et al., 2012; Gounder et al., 2014; Kwon et al., 2014). Ethical
concerns regarding the harms of getting tested, confidentiality of information, language
barrier, and/or a fear of getting deported can also play a role in testing of contacts
(Dewan et al., 2006; Fox et al., 2012; Kambali et al., 2015). The multivariate analysis
from this sample found that only age was significantly associated with testing in that the
older the person the less likely to accept TB testing. Age may be a proxy for knowledge
but might also reflect ingrained cultural beliefs, stigma or lack of access to health
services (Chakhaia et al., 2014; Faccini et al., 2015; Fox et al., 2015; Hargreaves et al.,
2011). Limited health literacy and language barrier is also common among older Asian
American immigrants, which prevents them from seeking healthcare service (Kim
&Keefe, 2010), such as TB screening.
Since the resurgence of TB in 1992, the focus on active case finding is among
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vulnerable population such as those with HIV, diabetes, malnutrition, and substance
abuse (WHO, 2013). The older (65 years of age and older) population was never a focus
of attention of TB screening (Negin, Abimbda & Marais, 2015). This was because older
adults were less likely to be part of TB outbreaks since their TB disease was more likely
due to reactivation from an earlier infection in life (Lee, et al., 2014; Horsburgh et al.,
2010; Winston and Navin, 2010). Increasing age, however, is significantly associated
with a positive TB test (Li et al., 2010; Pareek et al., 2013), and accounts for 21.9% TB
cases in the U.S. (Hochberg et al., 2013). This is due to increased reactivation of LTBI in
older adults from a weakened immune system (Thrupp et al., 2004), as well as increased
likelihood for co-morbidities that give rise to the development of active TB disease
(Seddon et al., 2013; Tsai et al., 2008). Older adults are also more likely to develop
extra-pulmonary TB such as tuberculous meningitis, renal or skeletal disease that often
makes it more difficult to diagnose and treat than pulmonary TB (Negin, Abimbda &
Marais, 2015). TB cases among older adults are associated with higher mortality rates
with 57% of all TB deaths globally occurring among those older than 50 years of age
(Negin, Abimbda & Marais, 2015). Therefore, enhanced testing and treatment of LTBI
should target older contacts. The waning immunity in older adults, however, can lead to
false-negative results on the TB skin test, thus either two-step testing or Interferon
Gamma Release Assay blood test (IGRA) should be considered. The latter is preferred
since results are less affected by age than TST (Hochberg et al., 2013: Seddon et al.,
2013; Shapiro, 2013).
Acceptance of TB Evaluation
Full evaluation of household contacts include both a chest-ray and physical
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examination at the DOHMH Chest Center, which takes about 2 to 3 hours. Nonacceptance of a full evaluation among household contacts in this sample was significantly
associated with male gender and those between the ages of 18-44. Some practical issues
such as difficulties in taking time off from work and school (Anger et al., 2012; Fox et
al., 2015; Gounder et al., 2014) or other personal reasons such as job security can prevent
a contact from coming for evaluation (Faccini et al., 2015). Since most males are head of
the household and are more likely to be responsible for a major part of the family’s
income, there will be an economic burden if the husband misses work (Hargreaves et al.,
2011).
An interesting finding in this study was that non-US born and Asian and Hispanic
contacts were more likely to complete the full evaluation. This is contradictory to others
who have reported that cultural barriers, stigma, and language barrier may play a role
among non-US born not coming for evaluation (Collins et al., 2003; Fox et al., 2015).
Asian American immigrants and Hispanics are more likely to have strong support system
(family and friends) that is associated with less psychological distress (Singh, McBridge,
Kak, 2015; Alegria, Sribney, & Mulvaney-Day, 2012) in seeking solutions to obtain TB
evaluation. Since Asians have the highest rate of TB in the U.S., they have been the
focus of TB screening among the non-US born (Demlow, Oh, & Barry, 2015) and may be
influenced by these targeted testing efforts over the last eight years to recruit them for full
evaluation. The DOHMH Bureau of TB Control has a diversified workforce with public
health advisors that speak different languages and dialects including Cantonese,
Mandarin, Fujinese, Taiwanese, Bengali, Hindi, Punjabi, and Tagalog. These advisors
address the language barrier and thus facilitate service for Asian immigrants.
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Household Contacts with LTBI
It is well documented that household contacts have an increased risk of becoming
tuberculin skin test (TST) and QuantiFERON test (QFT) positive (Lee et al., 2014;
Padmanesan et al., 2013) which is consistent with this study’s findings. A positive TB
test (evidence of LTBI), among household contacts was significantly associated with agegroup (18-44, 45-64, 65+), non-US born, race/ethnicity (Asian and Hispanic), and
borough (Brooklyn, Queens, and Staten Island). These findings were consistent with the
demographic characteristics of cases of active TB disease reported to the DOHMH from
2010 to 2016, except for male gender (BTBC, 2011; BTBC, 2012, BTBC, 2013, BTBC,
2014, BTBC, 2015, BTBC 2016). Contacts with LTBI in this study were not likely to be
male as found among the active TB cases of DOHMH or in other studies of household
contacts. This can be attributed to the fact that regardless of gender, proximity of the
contact to an infectious case of TB inside the household is a risk factor for LTBI (CDC,
2013; Padmanesan et al., 2013).
Acceptance/Completion of LTBI Treatment
For household contacts accepting/completing LTBI treatment, the significant
predictors were age-group (18-44), non-US born, and race/ethnicity (Asian and
Hispanics). Previous research did not find that age, country of birth, and race affects
adherence to treatment (Fiske et al., 2014; Naing et al., 2001), however, age was a
significant predictor in the acceptance/completion of LTBI treatment in this sample.
Those between the ages of 18-44 were less likely to accept/complete LTBI treatment.
Initiation of LTBI treatment is more of a major challenge than completion of LTBI
treatment (Goswami et al., 2012). Asians and Hispanics were more likely to
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accept/complete LTBI treatment, which is similar to another study (Goswami et al.,
2012). This can be attributed to the social support that Asians and Hispanics receive
(Singh, McBridge, Kak, 2015).
For household contacts refusing LTBI treatment, all age-groups and borough were
significant predictors. Except minors, all-age groups, most especially those ages 45-64
were more likely to refuse LTBI treatment. Household contacts from all age-groups
(except minors) who live in Staten Island, Brooklyn, and Queens were more likely to
refuse LTBI treatment. The large proportion in Brooklyn and Queens is due to the large
proportion of active TB cases, residing in these boroughs (BTBC, 2010; BTBC 2016).
Since 2010, there were two outbreaks of TB in Brooklyn where the majority were from
China. Between June 2010 and December 2014, there were a total of 23 confirmed
outbreaks in the same neighborhood in Brooklyn (Yacisin et al., 2015). These outbreaks
can be attributed to the social determinants of TB such as population mobility, and
overcrowding, which influence exposure to developing TB infection (Hargreaves et al.,
2011; Padmanesan et al., 2013). According to the US census from 2000-2010, there has
been a 52% increase of Hispanics and 78% increase of Asians in Staten Island. This
influx of non-US born contributes to overcrowding on Staten Island, which has had a
5.6% increase in population during this period (Lavis, 2013). Other factors described in
the literature review such as cultural barriers, stigma, and language barrier among nonUS born can give rise to poor communication between contacts and provider (Clough,
Lee, & Chae, 2013; Dresser at al., 2012). And providers who do not speak the language
of the patient may not effectively convey the importance of LTBI treatment (Global
tuberculosis Institute, n.d.).
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Demographic Characteristics
The significant findings in this study showed that the demographic characteristics
of household contacts associated with testing, evaluation, and LTBI treatment were
consistent with the demographic characteristics of active tuberculosis cases in NYC from
2010 to 2014 (BTBC 2011, BTBC, 2012, BTBC, 2013, BTBC, 2014, BTBC, 2015). TB
has adversely affected specific groups such as non-US born, Asian and Hispanic men in
the 18-44 age-group. The results of this study on older age group that was significant for
not getting tested and evaluated supports the 2017 findings of an increase in the number
of TB cases among 65 years old and older. TB is mostly found among those residing in
Queens and Brooklyn. These disparities contribute to an unequal distribution of the TB
prevalence in N.Y.C., and reflects the social determinants of TB, which influence
exposure to LTBI (Hargreaves et al., 2011; Padmanesan et al., 2013).
The findings on LTBI among household contacts were similar to a study
comparing several nationally representative cohorts of the US population participating in
the 1971-1972 and 1999-2000 National Health and Nutrition examination surveys (Khan
et al., 2008). The national study also identified sociodemographic factors such as
increasing age, male gender, African Americans, Hispanic Americans, foreign-born
individuals, and household contacts of active TB cases as having increased risk for LTBI.
Individuals who were either recently infected, or had co-morbidities or certain medical
conditions associated with progression from LTBI to active TB disease also were more at
risk for TB (ATS, 2000; CDC, 2016; Horsburg & Rubin, 2011; Khan et al., 2008).
Previous studies have shown that contact investigation should focus on household
contacts less than 5 years of age since they are more likely to get exposed to a case of TB
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in the home. However, regardless of age, proximity of the contact to an infectious case
of TB inside the household is the main factor in getting exposed to TB (CDC, 2013;
Padmanesan et al., 2013). Another study had shown a significant burden of LTBI among
males (Lee et al., 2014; Liang, et al., 1999). However, this study did not find gender as a
significant predictor on LTBI treatment. Age was the main demographic characteristic
that remained a significant predictor on all three points testing, evaluation, and LTBI
treatment.
Provider Type
The tuberculosis nurse case manager has an important role in TB testing and
evaluation in contact investigation (Mulder et al., 2012). In the Bureau of TB Control of
the DOHMH, the public health nurse was the primary case manager that facilitated
testing and evaluation of all contacts. In 2012, because of a shortage of nurses, the
Bureau expanded the role of Public Health Advisors (PHAs) to conduct health risk
assessment in contact investigation. This is similar to a study conducted by Shah that
with basic training, lay workers can provide support in conducting a contact investigation
(Shah et al., 2013). The finding from this study showed the proportion of household
contacts tested and evaluated did not differ between nurses and public health advisors,
which supports the policy of the Bureau of Tuberculosis Control to place PHAs as
primary case managers in response to the shortage of nurses. Among household contacts
testing positive, more contacts were not fully evaluated during the first period when
nurses were the primary case managers. This may have been due to the shortage nurses
to evaluate contacts. However, a higher proportion of household contacts that were fully
evaluated accepted LTBI treatment in July 2012-december 2014 than household contacts
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that were fully evaluated and accepted treatment in September 2010-June 2012.
Limitations
Since this is an analysis of secondary data collected for a TB registry, it does not
capture all information necessary to conduct a comprehensive analysis of factors
associated with household contacts accepting TB testing and evaluation, or completing
LTBI treatment. The area-based poverty level was not analyzed since analysis of data
was not done separately by year and area-based poverty level changes every year. The
TB registry includes about 76 countries as the country of birth of cases but did not reflect
the same number of countries as that of contacts. Country of birth of contacts did not
represent the same number that of cases. The type of LTBI treatment was not determined
since it was not part of the data set. Information that would be useful to a Department of
Health TB registry is the number of household contacts who accepted but did not
complete LTBI treatment, as well as other sociodemographic characteristics such as
education, which has been found to be a significant predictor of adherence to LTBI
treatment (Woimo et al, 2017). Another limitation was that almost half of the records for
the identified household contacts had missing data resulting in only about half of the total
sample available for data analysis. The TB registry consists of data collected for program
evaluation and not for research; however, incomplete data collection needs to be
addressed within the health department.
Research Recommendations
The next line of research after this study is to explore reasons for non-acceptance
to TB testing and evaluation, and LTBI treatment among those identified at high risk
such as age-group, male gender, non-US born, Asians and Hispanics. To properly
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address the social determinants of TB, this data should be link to national census data to
control for socio-economic status. Qualitative methods including focus groups and
individual interviews in the contact’s own language may reveal other social determinants
for non-adherence to testing, evaluations and treatment. Also, age-specific and genderspecific comorbidities of TB and behavioral risk factors such as tobacco, alcohol and
drug use would be useful to include in the registry. Knowing the health behavior of
contacts can help develop policies to incorporate TB screening as part of their overall
treatment. Environmental factors such as migration patterns, living conditions, access to
food, and health service that influence TB testing and evaluation should also be explored.
Digital analysis of testing, evaluation & LTBI treatment can be explored most especially
in boroughs where most outbreaks occurred. Adding new information to be collected will
need to be piloted to evaluate the PHA’s ability to accurately capture this information and
the time and cost implications of additional data collections. This can also be part of
effort to determine the effectiveness of non-nurse TB case manager in TB Control
program and what is needed in their training, continuing education and supervision to
improve their practice.
Practice Implications
The NYC DOHMH is similar to other Department of Health in the US in the use
of risk assessments forms in contact investigation (CDC, 2006; California Department of
Public Health, 2017; Virginia Department of Health, 2016; Minnesota Department of
Health, 2013; Missouri Department of Health and Senior Services, 2009). Risk
assessment of household contacts of active TB disease should be the standard practice
with an inclusion of older adults followed by appropriate testing, evaluation, and
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completion of LTBI treatment. Age and gender related barriers including comorbidities,
and contraindication to testing, evaluation, and treatment of LTBI should be identified;
and plans should be in place to address access needs for DOHMH services. Foreign, and
exchange students should follow immigration requirements on TB testing, evaluation &
LTBI treatment.
The goal of TB control should be to provide patient centered-care (Frieden, 2018)
and support outreach activities to bring TB screening to the community level such as the
use of a mobile screening unit (Morano et al., 2014; Morishita et al, 2017) and broader
educational effort on TB focused in high risk populations. This will promote awareness
in the community about the needs for TB screening and LTBI treatment. Health care
providers should be proactive in testing household contacts since delay on testing can
sustain TB transmission within the household and to the community (Padmanesan et al.,
2013; WHO, 2010). Health care providers need to be aware of the importance of LTBI
treatment in the prevention of active TB disease among household contacts.
Implementing socio-cultural intervention such as development of educational
materials that are culturally sensitive. Nurses should be able to provide coaching, and
counseling in the language the contacts speaks to enhance adherence to treatment,
especially among non-US born contacts (Clough, Lee, & Chae, 2013; Kim & Keefe,
2010). These interventions must be combined with the use of a shorter regimen (rifampin
for 4 months or the once a week treatment of isoniazid & rifapentine for 12 weeks) to
enhance LTBI treatment completion.
The TB registry included considerable incomplete data. A follow-up with clients
should be documented when records are incomplete. New innovative tools with the use
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of telecommunication technologies can be adopted to help track clients from testing to
evaluation, to initiation and completion of LTBI treatment. A study on the use of twoway text messaging to follow-up adherence to LTBI treatment among contacts has shown
promising results and thus should be further explored (Hermans et al., 2017; Johnston et
al., 2018).
In order to improve data quality accuracy of the TB registry, the data entry
process should be limited to designated staff assigned for data entry. Supervisors need to
ensure that staff entering data are not overburdened and have limits on data entry input
per day. This may include efficient delegation to other cross-trained staff, if the bulk of
data entry exceeds a daily limit. In addition, quality assurance staff should conduct
regularly scheduled data review and double-check the data entered. A data entry quality
control method to increase accuracy of data entry such as double key entry verification or
two-pass verification can be useful for the correction of random and miskeyed strokes
(Coleman Data Solutions, 2014).
Policy Implications
The new WHO guidelines recommend adults, adolescents, and children who are
household contacts of confirmed pulmonary TB should be systematically tested and
treated for LTBI (WHO, 2018). Previous studies demonstrate the cost-effectiveness of
testing and treating non-US born for LTBI. Testing and treatment of LTBI is cost
effective regardless of age compared with no testing (Flood and Barry, 2017; Tasillo et
al., 2017) and only effective when administered to contacts of active TB (Zammarchi et
al., 2015). To enhance testing among the non-US born, hiring of more bilingual staff
should be promoted to address the language barrier, and possible use of mobile apps to
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assist follow-up contacts for evaluation. The new recommendation for testing LTBI
include either a TST or Interferon Gamma Release Assay except in contacts with HIV or
less than 5 years of age who can be started on LTBI treatment without testing (WHO,
2018).
It is expected that testing and LTBI treatment will reduce the overall incidence of
TB (Denholm & McBryde, 2014; Dye et al., 2013; Hill, Becerra & Castro, 2012; Houben
et al., 2016; Varughese et al., 2014). However, providing TB testing to all non-US born
persons requires extensive resources, and may not be feasible because of inadequate
funding. Therefore, it is critical to identify factors that will contribute to acceptance of
testing, evaluation, and treatment of LTBI among non-US born.
In addition, the rapid population growth and mobility of the immigrant population
in N.Y.C. gives rise to the unequal distribution of the social determinants of TB such as
overcrowding, cultural barriers, and access to health care. Scaling up of interventions
such as testing and LTBI treatment by addressing the specific social determinants of TB,
including undocumented immigrants, and refugees will likely improve the health
situation of non-US born population (Hargreaves et al., 2011; Lonnroth et al., 2009; Reid
et al., 2015). Educating legislators and stakeholders to the disparities of TB most
especially among the Asian and Hispanic groups will help reduce racial disparities of TB
in these groups (CDC, 2004). Adequate social support can prevent delays in the
diagnosis of person with symptoms of TB and prevent spread transmission of TB to
household members (Bonadonn et al., 2017; Padmanesan et al., 2013). Moreover,
developing interventions to address other risk factors associated with TB such as
homelessness, HIV, and substance abuse will help reduce TB morbidity. Policy
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recommendation to public health agencies include allocating funding for TB screening to
the community level such as the use of mobile testing unit. The DOHMH would benefit
from expanding partnerships with both public and private sectors in promoting TB
testing, evaluation, and treatment for LTBI. For example, community basedorganizations need to be empowered to participate in TB screening. In some high risk
populations, agencies may consider promoting adherence by providing incentives for
clients to complete LTBI treatment.
Conclusion
Understanding factors associated with TB testing and evaluation, and LTBI
treatment will enable public health agencies to streamline the process of contact
investigation and plan for effective strategies that will increase the number of household
contacts to accept TB testing and evaluation, as well as accepting/completing LTBI
treatment. LTBI treatment is essential in decreasing the incidence of TB disease, which
is critical in TB elimination. Standardization of data entry processes to improve data
collection not just for program planning but for operational research is also essential in
TB control.
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Figure A3. Results of the search according to PRISMA guidelines (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses).
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Table A4. Definitions Used in the Integrative Review
Term
Case Management

Case managers

Close contact

Concentric circle

Contact

Contact investigation
(CI)

Contact with active
TB/Secondary case

Contact with LTBI

Evaluation

Household contact

Index case/active TB
disease

Infectious period

Invitation model

Definition
Dynamic and systematic
collaborative approach to providing
and coordinating health care services
to meet an individuals’ health needs
A person in charge of managing and
coordinating health care needs of the
patient
A person who is not in the household
but shares an enclosed space with the
index case
A method of testing close contacts in
order of their intensity and time of
exposure and risk of being infected
Any person who has been exposed to
an index case or was in the same
place as the index case during the
infectious period
A process of identifying, testing,
evaluating, and treating all persons
who are at risk for infection with M.
tb due to recent exposure to an index
case
A contact person with confirmed
positive sputum culture for M. tb
during the baseline CI. A new case
of active TB disease
Any contact person with a positive
TST/IGRA and normal x-ray finding
who did not have active TB disease
during baseline CI
Is when a person with positive
results on TB testing accepts
evaluation
A person who shared the same
household as the index case during
the 3 months before initiation of
treatment
A person with confirmed infectious
active pulmonary, laryngeal, or
pleural TB disease with positive
sputum smear and culture
The infectious period is 3 months
before the index case started anti-TB
treatment, based on guidelines for CI

A method in which an index case is
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BTBC, 2008; CDC, 2011;
Chakhaia et al., 2014; Fair et
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asked to invite his or her contacts to
be examined at a health care facility
An infection with M. tb organisms
BTBC, 2008; CDC, 2011
Latent TB infection
that causes no signs or symptoms
and no radiographic or bacteriologic
evidence of TB disease
Multi-drug-resistant TB; active TB
Anderson et al., 2014; BTBC,
MDR-TB
disease resistant to more than one
2008; CDC, 2011
drug
A contact not in the same household CDC, 2011; Kwon et al., 2014
Non-household
as the index case. It can be any
contact
congregate setting such as a school,
military facility, office or workplace,
jail or prison, social welfare facility,
etc.
A nurse who uses the nursing
CDC, 2011
Nurse case manager
process to develop, implement, and
evaluate individualized patient care
plans
Two or more contacts are identified
CDC, 2005
Outbreak
as having active TB during a CI
regardless of their assigned priority
A blood test administered to know if CDC, 2011
QuantiFERON
the person has been exposed to TB
TB control strategy used to identify, CDC, 2011
Targeted Testing
evaluate, and treat persons who are
at risk for LTBI or at high risk for
developing Tb disease once infected
with M. tb
Evaluation of persons with positive
CDC, 2011
TB evaluation
TB test results that include Chest-xray and medical evaluation made by
health care provider
Is when a person accepts TB tests to CDC, 2011
Testing
know if she/he has been exposed to
TB
Tuberculin Skin Test A test that is administered under the CDC, 2011
layer of the skin to know if the
person has been exposed to TB
CI, contact investigation; IGRA, interferon-gamma release assay; MDR-TB, multi-drug-resistant
TB; M. tb, Mycobacterium tuberculosis; TB, tuberculosis; TST, tuberculin skin test.
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Table A8. Demographic Characteristics of All Household Contacts of Active TB
Cases (n=3,008)
Demographics
Gender
Male
Female
Age-Group
0-17
18-44
45-64
65+
Country of Birth
US-Born
Non-US Born
Race/Ethnicity
Non-Hispanic Black
Hispanic
Asian
Non-Hispanic White
Other
Borough
Bronx
Brooklyn
Manhattan
Queens
Staten Island

Frequency
N=3008

Percentage

1493
1515

49.63
50.37

865
1322
640
181

28.76
43.95
21.28
6.02

1006
2002

33.44
66.56

583
969
1175
176
105

19.38
32.21
39.06
5.85
3.49

482
934
216
1311
65

16.02
31.05
7.18
43.58
2.16
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Table A9. Demographic Characteristics of Household Contacts Tested/Not Tested
for TB (n = 3,008)
Demographics
Gender
Male
Female
Age-Group
0-17
18-44
45-64
65+
Country of Birth
US-Born
Non-US Born
Race/Ethnicity
Non-Hispanic
Black
Hispanic
Asian
Non-Hispanic
White
Other
Borough
Bronx
Brooklyn
Manhattan
Queens
Staten Island

# of Contacts
N=3008

# Tested
N= 2850

# Not Tested
N=158

p-Value
0.505

1493
1515

1410 (94.44%)
1440 (95.05%)

83 (5.56%)
75 (4.95%)
0.001

865
1322
640
181

854 (98.73%)
1234 (93.34%)
595 (92.97%)
167 (92.27%)

11 (1.27%)
88 (6.66%)
45 (7.03%)
14 (7.73%)
0.001

1006
2002

973 (96.72%)
1877 (93.76%)

33 (3.28%)
125 (6.24%)
0.022

583

543 (93.14%)

40 (6.86%)

969
1175
176

922 (95.15%)
1127 (95.91%)
162 (92.05%)

47 (4.85%)
48 (4.09%)
14 (7.95%)

105

96 (91.43%)

9 (8.57%)
0.452

482
934
216
1311
65

459 (95.23%)
888 (95.07%)
206 (95.37%)
1233 (94.05%)
64 (98.46%)

23 (4.77%)
46 (4.93%)
10 (4.63%)
78 (5.95%)
1 (1.54%)
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Table A10. Demographic Characteristics of Household Contacts Testing Positive
versus Negative (n=2,850)
Demographics

Total
N=2850

Positive
N=1090

Negative
N=1760

Gender

0.0295

Male

1410

568 (40.28%)

842 (59.72%)

Female

1440

522 (36.25%)

918 (63.75%)

Age-Group
0-17
18-44
45-64
65+
Country of Birth
US-Born
Non-US Born
Race/Ethnicity
Non-Hispanic
Black
Hispanic
Asian
Non-Hispanic
White
Other
Borough
Bronx
Brooklyn
Manhattan
Queens
Staten Island

p-Value

0.000
854
1234
595
167

187 (21.90%)
528 (42.79%)
296 (49.75%)
79 (47.31%)

667 (78.10%)
706 (57.21%)
299 (50.25%)
88 (52.69%)

973
1877

178 (18.29%)
912 (48.59%)

795 (81.71%)
965 (51.41%)

0.000

0.000
543

159 (29.28%)

384 (70.72%)

922
1127
162

355 (38.50%)
475 (42.15%)
51 (31.48%)

567 (61.50%)
652 (57.85%)
111 (68.52%)

96

50 (52.08%)

46 (47.92%)

459
888
206
1233
64

117 (25.49%)
340 (38.29%)
76 (36.89%)
533 (43.23%)
24 (38.50%)

342 (74.51%)
548 (61.71%)
130 (63.11%)
700 (56.77%)
40 (62.50%)

0.000
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Table A11. Demographic Characteristics of Household Contacts Fully Evaluated
versus Not Fully Evaluated (n=1,090)
Demographics

Total
N=1090

Fully Evaluated
N=1037

Not Fully
Evaluated
N=53

Gender

0.002

Male

568

529 (93.13%)

39 (6.87%)

Female

522

508 (97.32%)

14 (2.68%)

Age-Group
0-17
18-44
45-64
65+
Country of Birth
US-Born
Non-US Born
Race/Ethnicity
Non-Hispanic
Black
Hispanic
Asian
Non-Hispanic
White
Other
Borough
Bronx
Brooklyn
Manhattan
Queens
Staten Island

p-Value

0.014
187
528
296
79

186 (99.47%)
494 (93.56%)
281 (94.93%)
76 (96.20%)

1 (0.53%)
34 (6.44%)
15 (5.07%)
3 (3.80%)
0.002

178
912

178 (100.00%)
859 (94.19%)

0 (0.00%)
53 (5.81%)

159

153 (96.23%)

6 (3.77%)

355
475
51

335 (94.37%)
455 (95.79%)
47 (92.16%)

20 (5.63%)
20 (4.21%)
4 (7.84%)

50

47 (94.00%)

3 (6.00%)

0.513

0.039
117
340
76
533
24

112 (95.73%)
332 (97.65%)
70 (92.11%)
499 (93.62%)
24 (100.00%)

5 (4.27%)
8 (2.35%)
6 (7.89%)
34 (6.38%)
0 (0.00%)
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Table A12. Demographic Characteristics of Household Contacts Accepted versus
Refused LTBI Treatment (n=863)
Demographics

Total
N=863

Accepted/Completed
LTBI Tx
N=657

Refused
LTBI Tx
N=206

Gender

0.910

Male

424

324 (76.42%)

100 (23.58%)

Female

439

333 (75.85%)

106 (24.15%)

Age-Group
0-17
18-44
45-64
65+
Country of Birth
US-Born
Non-US Born
Race/Ethnicity
Non-Hispanic
Black
Hispanic
Asian
Non-Hispanic
White
Other
Borough
Bronx
Brooklyn
Manhattan
Queens
Staten Island

p-Value

0.001
169
403
234
57

162 (95.86%)
290 (71.96%)
165 (70.51%)
40 (70.18%)

7 (4.14%)
113 (28.04%)
69 (29.49%)
17 (29.82%)
0.001

159
704

143 (89.94%)
514 (73.01%)

16 (10.06%)
190 (26.99%)

128

93 (72.66%)

35 (27.34%)

266
392
37

224 (84.21%)
291 (74.23%)
23 (62.16%)

42 (15.79%)
101 (25.77%)
14 (37.84%)

40

26 (65.00%)

14 (35.00%)

0.001

0.002
88
289
51
414
15

81 (92.05%)
206 (71.28%)
37 (72.55%)
318 (76.81%)
15 (71.43%)

7 (7.95%)
83 (28.72%)
14 (27.45%)
96 (23.19%)
6 (28.57%)
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Table A13. Household Tested, Fully Evaluated, and Accepted/Completed LTBI
treatment between September 2010-July 2012 versus July 2012-December 2014
Variables
Testing
Tested
Not Tested
Test Result
Positive
Negative
Evaluation
Fully Evaluated
Not Fully
Evaluated
LTBI Treatment
Accepted
Refused

Contacts
N=3008

Sept. 2010-June
2012

July 2012-Dec.
2014

2850
158

1220 (95.16%)
62 (4.84%)

1630 (94.44%)
96 (5.56%)

p-Value
0.424

0.001
1090
1760

536 (44.93%)
684 (56.07%)

554 (33.99%)
1076 (66.01%)
0.126

1037
53

504 (94.03%)
32 (5.97%)

533 (96.21%)
21 (3.79%)
0.101

657
206

303 (73.90%)
107 (26.10%)

354 (78.15%)
99 (21.85%)
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Table A14. Summary of Significant Predictors
Univariate Analysis
Tested for TB

TB +/-(evidenced of
LTBI)

Fully Evaluated/
Not Fully Evaluated

Accepted LTBI Tx

Refused LTBI Tx

Multivariate Analysis

Characteristic

Table

Characteristic

Table

Age-group
Non-US born
Race/Ethnicity
Male
Age Group
Non-US born
Race/Ethnicity
Borough
Male Gender
Age-group
Non-US born
Borough
Age-group
Non-US born
Race Ethnicity
Borough
Age-group
Non-US born
Race/Ethnicity
Borough

3
4
5
7
8
9
10
11
12
13
14
16
18
19
20
21
22
19
20
21

Age-group

26

Age Group
Non-US born
Borough

27
27
27

Male Gender
Age-group
Non-US born
Race/Ethnicity
Age-group
Non-US born
Race/Ethnicity

28
28
28
28
29
29
29

Age-group

30

Borough

30
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